{ "company": "Thermo Fisher Scientific", "ticker": "TMO", "period": { "from": "2026-03-25", "to": "2026-04-24", "days": 30 }, "sentiment_breakdown": { "positive": 77, "negative": 41, "neutral": 83 }, "synthesis": { "executive_summary": "Sentiment analysis for Thermo Fisher Scientific (TMO) from 2026-03-25 to 2026-04-24. Analyzed 201 items across FDA and news sources.", "key_findings": [], "overall_sentiment": "neutral" }, "top_positive": [ { "title": "Cell Free Expression Industry Set to Reach USD 627 Million by 2035 - Investment in Cell Free Systems Surpasses USD 8 Billion in Last Six Years", "date": "2026-04-20", "source": "news", "score": 0.962 }, { "title": "Cardiff stun Scarlets with late URC fightback", "date": "2026-04-18", "source": "news", "score": 0.931 }, { "title": "Cardiff stun Scarlets with late URC fightback", "date": "2026-04-18", "source": "news", "score": 0.931 }, { "title": "Single Use Bioprocessing Markets and Competition Insights Report 2026 - Industry Set to Triple in Value by 2035, Reaching USD 15.5 Billion", "date": "2026-04-20", "source": "news", "score": 0.914 }, { "title": "Connacht comeback stuns Stormers in Cape Town", "date": "2026-04-18", "source": "news", "score": 0.91 }, { "title": "Connacht comeback stuns Stormers in Cape Town", "date": "2026-04-18", "source": "news", "score": 0.91 }, { "title": "Softgel Capsules Market Analysis Report 2025 - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030", "date": "2026-04-20", "source": "news", "score": 0.906 }, { "title": "Nanotechnology Market to Grow at 13.21% CAGR to Reach USD 220.8 Billion by 2031, Supported by Healthcare Expansion and Clean Energy Initiatives, Reports Mordor Intelligence", "date": "2026-04-15", "source": "news", "score": 0.883 }, { "title": "Cell Line Characterization and Cell Line Development Market Trends and Global Forecasts 2025-2035: 200+ Biologics Entered the Market with More Than 10,000 Candidates Undergoing Clinical Assessment", "date": "2026-04-20", "source": "news", "score": 0.881 }, { "title": "Ospreys hold on to deny Sharks in Bridgend", "date": "2026-04-18", "source": "news", "score": 0.878 } ], "top_negative": [ { "title": "Donald Trump’s Racism Mirrors Jeffrey Epstein’s", "date": "2026-04-16", "source": "news", "score": -0.938 }, { "title": "Template-driven scaffolding of SCFFBXO42 regulates PP2A degradation", "date": "2026-04-15", "source": "news", "score": -0.869 }, { "title": "Three Fatal Gestational Psittacosis Cases Caused by Chlamydia psittaci Strains Belonging to Closely Related Lineages, Japan", "date": "2026-04-16", "source": "news", "score": -0.848 }, { "title": "Focal white matter lesions drive grey matter inflammation and synapse loss", "date": "2026-04-22", "source": "news", "score": -0.799 }, { "title": "Antitumoral immunity induced by gel ethanol ablation to treat unresectable colorectal cancer metastases in the liver", "date": "2026-04-22", "source": "news", "score": -0.796 }, { "title": "Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer", "date": "2026-04-22", "source": "news", "score": -0.727 }, { "title": "Impact of tumor location on the efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.", "date": "2026 Apr 9", "source": "pubmed", "score": -0.718 }, { "title": "Entry, replication and innate immunity evasion of BANAL-236, a SARS-CoV-2-related bat virus, in Rhinolophus and human cells", "date": "2026-04-20", "source": "news", "score": -0.7 }, { "title": "Immune-related gene expression profiling and alectinib efficacy for patients with ALK-Rearranged non-small cell lung cancer: exploratory analysis of a prospective observational study.", "date": "2026 Apr 1", "source": "pubmed", "score": -0.66 }, { "title": "Structure of the human P2X3 receptor reveals the basis for subtype-selective inhibition by sivopixant", "date": "2026-04-22", "source": "news", "score": -0.637 } ], "raw_data": { "total_items": 201, "items": [ { "source": "alpha_vantage", "title": "Does Agilent (A) Settling Axion Dispute Clarify Its Push Into Cloud Lab Data Recurring Revenues?", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-a/agilent-technologies/news/does-agilent-a-settling-axion-dispute-clarify-its-push-into", "date": "2026-04-24", "summary": "Agilent Technologies recently settled a confidential dispute with Axion BioSystems, which, while immaterial to near-term financials, removes a legal overhang. This resolution aligns with Agilent's strategy to expand its recurring software and data-management revenues in the growing Cloud Electronic Laboratory Notebook market. The company aims to offset tariff pressures and capital spending cyclicality through higher-margin software solutions.", "sentiment_score": 0.136381, "sentiment_label": "Neutral", "relevance_score": 0.62214, "sentiment": { "label": "negative", "score": -0.402, "confidence": 0.4 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific (TMO) Margin Hold At 15% Tests Long Term Earnings Concerns", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/thermo-fisher-scientific-tmo-margin-hold-at-15-tests-long-te", "date": "2026-04-24", "summary": "Thermo Fisher Scientific (TMO) reported Q4 2025 revenue of US$12.2 billion and basic EPS of US$5.22, with trailing twelve-month revenue at US$44.6 billion and a net margin of 15%. While recent profitability improved with 5.8% earnings growth, this stands against a five-year earnings decline of 6.1% annually, raising concerns about long-term growth and debt coverage despite a P/E ratio below the industry average. The company's current valuation and forecasts present a mixed picture for investors ", "sentiment_score": 0.142153, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "How Thermo Fisher built FluidEase Pro, its first touchscreen pipette, over 2.5 years and 20 software revisions", "url": "https://www.rdworldonline.com/how-thermo-fisher-built-fluidease-pro-its-first-touchscreen-pipette-over-2-5-years-and-20-software-revisions/", "date": "2026-04-23", "summary": "Thermo Fisher Scientific developed the FluidEase Pro ClipTip, its first handheld pipette with a large touchscreen, over 2.5 years and 20 software revisions. The device features a 2-inch IPS LCD touchscreen, Bluetooth 5.0 connectivity, multiple user profiles, and electronic tip ejection, aiming to improve lab efficiency and reduce repetitive strain injuries. Customer feedback significantly influenced its design, including a rotating finger rest to accommodate different users.", "sentiment_score": 0.40149, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Organic Revenue Flat, Stock Price Drops for Thermo Fisher Scientific", "url": "https://www.wfmz.com/business/organic-revenue-flat-stock-price-drops-for-thermo-fisher-scientific/article_19b8df47-3194-48c7-a7c4-c5c689ba413e.html", "date": "2026-04-23", "summary": "Thermo Fisher Scientific experienced an unusual stock drop of over 10% despite reporting better-than-expected first-quarter sales and profit results. Analysts are concerned about the company's long-term prospects due to organic revenue growth of only 1.6% over the past two years and a steady decline in adjusted operating margin over five years. Despite these concerns, analysts still consider Thermo Fisher to be a strong company in the healthcare sector.", "sentiment_score": -0.246148, "sentiment_label": "Somewhat-Bearish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Danaher’s €3b Euro Debt Issue And What It Means For Valuation", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher/news/danahers-3b-euro-debt-issue-and-what-it-means-for-valuation", "date": "2026-04-23", "summary": "Danaher (NYSE:DHR) has launched a significant €3 billion euro-denominated debt offering through senior notes to fund its pending acquisition of Masimo Corporation. This move introduces a new component to Danaher's capital structure, and investors should monitor future interest expenses, leverage ratios, and the integration of Masimo. Despite recent stock weakness, analysts view Danaher as undervalued, noting its strong balance sheet despite increased debt.", "sentiment_score": 5.4e-05, "sentiment_label": "Neutral", "relevance_score": 0.596714, "sentiment": { "label": "negative", "score": -0.361, "confidence": 0.36 } }, { "source": "alpha_vantage", "title": "Thermo Fisher CEO says onshoring push will bring a ‘tailwind’ for the Waltham company", "url": "https://www.bizjournals.com/boston/news/2026/04/23/thermo-fisher-us-manufacturing.html", "date": "2026-04-23", "summary": "Thermo Fisher Scientific CEO Marc Casper stated that the Waltham-based company is already benefiting from domestic manufacturing efforts, anticipating further growth in the coming years. This \"tailwind\" is expected to be buoyed by onshoring initiatives, with former President Donald Trump having recently toured a Thermo Fisher facility to highlight his administration's focus on lowering drug prices and boosting domestic production.", "sentiment_score": 0.425011, "sentiment_label": "Bullish", "relevance_score": 0.952164, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market", "url": "https://www.marketwatch.com/data-news/thermo-fisher-scientific-inc-stock-falls-thursday-underperforms-market-acab3b67-659ce3ff98ea", "date": "2026-04-23", "summary": "Thermo Fisher Scientific Inc. (TMO) shares fell 9.20% on Thursday, closing at $466.70. This decline occurred during an overall poor trading day, as the S&P 500 Index (SPX) dropped 0.41% and the Dow Jones Industrial Average (DJIA) fell 0.36%. This marks the fourth consecutive day of losses for the stock.", "sentiment_score": -0.408347, "sentiment_label": "Bearish", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Thermo Fisher falls after earnings top estimates, but growth concerns persist", "url": "https://www.proactiveinvestors.com/companies/news/1091089/thermo-fisher-falls-after-earnings-top-estimates-but-growth-concerns-persist-1091089.html", "date": "2026-04-23", "summary": "Thermo Fisher Scientific's shares fell over 7.5% despite beating first-quarter earnings estimates, as investors focused on modest underlying organic growth and a cautious outlook. While adjusted earnings per share and revenue both exceeded expectations, acquisitions drove a significant portion of the revenue increase, with organic growth at only 1%. The company raised its full-year revenue outlook but it remains slightly below consensus estimates, contributing to investor concerns about future g", "sentiment_score": -0.421527, "sentiment_label": "Bearish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.586, "confidence": 0.59 } }, { "source": "alpha_vantage", "title": "Thermo Fisher (TMO) Q1 2026 Earnings Transcript", "url": "https://www.fool.com/earnings/call-transcripts/2026/04/23/thermo-fisher-tmo-q1-2026-earnings-transcript/", "date": "2026-04-23", "summary": "Thermo Fisher Scientific reported a strong start to 2026, with Q1 revenue up 6% to $11.01 billion and adjusted EPS increasing 6% to $5.44. The company raised its full-year 2026 guidance, boosted by the acquisition of Clario and robust operational performance. Key growth drivers included bioproduction and clinical research, while academic and government segments faced muted demand, particularly in the U.S. and China.", "sentiment_score": 0.490031, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Cumberland Pharmaceuticals to sell branded drug unit to Apotex for $100M", "url": "https://www.investing.com/news/company-news/cumberland-pharmaceuticals-to-sell-branded-drug-unit-to-apotex-for-100m-93CH-4632724", "date": "2026-04-23", "summary": "Cumberland Pharmaceuticals announced an agreement to sell its branded pharmaceutical line to an affiliate of Apotex for $100 million in cash, a deal representing more than twice Cumberland’s current market capitalization. The company will retain its product pipeline and its majority ownership in Cumberland Emerging Technologies Inc. Cumberland is actively developing ifetroban, a thromboxane antagonist, through three separate programs, including one for Duchenne muscular dystrophy with FDA design", "sentiment_score": 0.335462, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.600432, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "GE HealthCare to Post Q1 Earnings: What's in Store for the Stock?", "url": "https://www.tradingview.com/news/zacks:79dcafb13094b:0-ge-healthcare-to-post-q1-earnings-what-s-in-store-for-the-stock/", "date": "2026-04-23", "summary": "GE HealthCare Technologies Inc. (GEHC) is set to report its first-quarter 2026 earnings on April 29, with analysts anticipating sustained low-to-mid-single-digit organic revenue growth despite challenges in China and tariff-related costs. The company's prior quarter showed an earnings beat, and the upcoming report is expected to highlight strong performance in Pharmaceutical Diagnostics and stable growth in Imaging. However, a neutral Earnings ESP and a Zacks Rank #3 suggest the prediction for a", "sentiment_score": 0.263418, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.716717, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Reports First Quarter 2026 Results", "url": "https://www.pharmiweb.com/press-release/2026-04-23/thermo-fisher-scientific-reports-first-quarter-2026-results", "date": "2026-04-23", "summary": "Thermo Fisher Scientific reported strong first-quarter 2026 results, with revenue up 6% to $11.01 billion and diluted EPS growing 11% to $4.43. The company highlighted new product launches, strategic collaborations with NVIDIA and SHL Medical, and the acquisition of Clario, along with stock repurchases and a dividend increase. Thermo Fisher CEO Marc N. Casper emphasized excellent execution, the company's PPI Business System, and its commitment to driving innovation and customer success.", "sentiment_score": 0.51484, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Reports First Quarter 2026 Results", "url": "https://www.biospace.com/press-releases/thermo-fisher-scientific-reports-first-quarter-2026-results", "date": "2026-04-23", "summary": "Thermo Fisher Scientific announced strong first quarter 2026 results, with revenue growing 6% to $11.01 billion and adjusted diluted EPS increasing 6% to $5.44. The company highlighted its growth strategy through innovative product launches, strategic collaborations with NVIDIA and SHL Medical, and successful capital deployment including the acquisition of Clario and a 10% dividend increase. Management expressed confidence in delivering a strong year, emphasizing operational excellence and custo", "sentiment_score": 0.60714, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher ranks sixth by Quant as stock falls on Q1 results (TMO:NYSE)", "url": "https://seekingalpha.com/news/4578555-thermo-fisher-ranks-sixth-by-quant-as-stock-falls-on-q1-results", "date": "2026-04-23", "summary": "Thermo Fisher Scientific (TMO) shares declined in premarket trading despite exceeding Q1 2026 revenue expectations, as weaker-than-expected organic growth raised concerns about demand. The company's stock currently holds a \"Hold\" rating and ranks sixth among its life sciences tools peers by Seeking Alpha's Quant Ratings, which assess valuation, growth, momentum, and profitability.", "sentiment_score": -0.26894, "sentiment_label": "Somewhat-Bearish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific slides 3% despite solid financial report 📉", "url": "https://www.xtb.com/int/market-analysis/news-and-research/thermo-fisher-scientific-slides-3-despite-solid-financial-report", "date": "2026-04-23", "summary": "Thermo Fisher Scientific reported strong first-quarter 2026 results, surpassing market expectations for adjusted EPS and revenue, yet its shares dipped 3% in premarket trading. The negative investor reaction is primarily attributed to weak organic revenue growth of only 1%, indicating that most expansion was driven by acquisitions rather than core business performance. Despite new product launches and strategic partnerships, the market prioritized the quality of underlying business growth over t", "sentiment_score": -0.287422, "sentiment_label": "Somewhat-Bearish", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.114, "confidence": 0.11 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific slides 3% despite solid financial report 📉", "url": "https://www.xtb.com/en/market-analysis/thermo-fisher-scientific-slides-3-despite-solid-financial-report", "date": "2026-04-23", "summary": "Thermo Fisher Scientific's shares declined by 3% in premarket trading despite reporting first-quarter 2026 results that surpassed market expectations for adjusted EPS and revenue. While the company saw 6% year-over-year growth in both metrics, organic revenue growth was a mere 1%, suggesting that acquisitions rather than core business strength drove expansion. The market reacted negatively, emphasizing the importance of underlying business growth quality over just beating estimates.", "sentiment_score": 0.076239, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.114, "confidence": 0.11 } }, { "source": "alpha_vantage", "title": "THERMO FISHER SCIENTIFIC ($TMO) Releases Q1 2026 Earnings", "url": "https://www.quiverquant.com/news/THERMO+FISHER+SCIENTIFIC+%28%24TMO%29+Releases+Q1+2026+Earnings", "date": "2026-04-23", "summary": "Thermo Fisher Scientific (TMO) announced its Q1 2026 earnings, reporting $5.44 per share, surpassing analyst estimates of $5.28. The company's revenue reached $11.005 billion, also exceeding estimates by over $45 million. The article also details recent insider trading activity, hedge fund movements, government contracts, congressional stock transactions, and analyst ratings and price targets for TMO.", "sentiment_score": 0.317418, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific reports Q1 2026: Revenue $11.01B, GAAP diluted EPS $4.43, Adjusted EPS $5.44", "url": "https://www.tradingview.com/news/tradingview:0e121427cd3e8:0-thermo-fisher-scientific-reports-q1-2026-revenue-11-01b-gaap-diluted-eps-4-43-adjusted-eps-5-44/", "date": "2026-04-23", "summary": "Thermo Fisher Scientific reported strong first-quarter 2026 results, with revenue reaching $11.01 billion and GAAP diluted EPS increasing 11% year-over-year to $4.43. The company also announced an adjusted diluted EPS of $5.44, up 6%, and highlighted active capital deployment including the acquisition of Clario, $3.0 billion in share repurchases, and a 10% dividend increase. Significant business developments included new product launches and strategic collaborations to advance scientific instrum", "sentiment_score": 0.456939, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher: Q1 Earnings Snapshot", "url": "https://www.kvue.com/article/syndication/associatedpress/thermo-fisher-q1-earnings-snapshot/616-23bd561b-ebd9-447b-a698-a4ea10e2f9e9", "date": "2026-04-23", "summary": "Thermo Fisher Scientific Inc. reported first-quarter net income of $1.65 billion, or $4.43 per share. Adjusted earnings were $5.44 per share, surpassing analyst expectations of $5.20 per share. The company's revenue of $11.01 billion also exceeded Street forecasts of $10.83 billion.", "sentiment_score": 0.539581, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Earnings Flash (TMO) Thermo Fisher Scientific Inc. Reports Q1 Revenue $11.01B, vs. FactSet Est of $10.86B", "url": "https://www.marketscreener.com/news/earnings-flash-tmo-thermo-fisher-scientific-inc-reports-q1-revenue-11-01b-vs-factset-est-of-1-ce7f59d9de89f622", "date": "2026-04-23", "summary": "Thermo Fisher Scientific Inc. (TMO) reported its Q1 revenue at $11.01 billion, exceeding the FactSet estimate of $10.86 billion. This news indicates a positive financial performance for the company in the first quarter, surpassing analyst expectations. The report suggests strong operational results for Thermo Fisher Scientific.", "sentiment_score": 0.410091, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Reports First Quarter 2026 Results", "url": "https://www.businesswire.com/news/home/20260422657369/en/Thermo-Fisher-Scientific-Reports-First-Quarter-2026-Results", "date": "2026-04-23", "summary": "Thermo Fisher Scientific (NYSE: TMO) reported a strong start to 2026 with first-quarter revenue increasing 6% to $11.01 billion and GAAP diluted EPS growing 11% to $4.43. The company highlighted strategic advancements including new product launches, collaborations with NVIDIA and SHL Medical, and the acquisition of Clario. Marc N. Casper, chairman and CEO, attributed the success to the company's growth strategy and PPI Business System, expressing optimism for the full year.", "sentiment_score": 0.4472, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "[8-K] THERMO FISHER SCIENTIFIC INC. Reports Material Event", "url": "https://www.stocktitan.net/sec-filings/TMO/8-k-thermo-fisher-scientific-inc-reports-material-event-cdcd9fc4e15e.html", "date": "2026-04-23", "summary": "Thermo Fisher Scientific Inc. reported Q1 2026 results including a 6% revenue increase to $11.01 billion and an 11% rise in GAAP diluted EPS to $4.43. The company also announced the acquisition of Clario, repurchased $3.0 billion in stock, and increased its dividend by 10%. Management will provide updated 2026 guidance during their earnings conference call.", "sentiment_score": 0.389011, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher tops $11B in quarterly sales, lifts dividend 10%", "url": "https://www.stocktitan.net/news/TMO/thermo-fisher-scientific-reports-first-quarter-2026-zubscfup7iu4.html", "date": "2026-04-23", "summary": "Thermo Fisher Scientific reported strong first-quarter 2026 results, with revenue growing 6% to $11.01 billion and adjusted diluted EPS increasing by 6% to $5.44. The company highlighted successful execution of its growth strategy, including new product launches, strategic collaborations with NVIDIA and SHL Medical, and the acquisition of Clario. Additionally, Thermo Fisher repurchased $3.0 billion of stock and raised its dividend by 10%, demonstrating confidence in its financial performance and", "sentiment_score": 0.408869, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.511, "confidence": 0.51 } }, { "source": "alpha_vantage", "title": "Thermo Fisher: Q1 Earnings Snapshot", "url": "https://www.ktvb.com/article/syndication/associatedpress/thermo-fisher-q1-earnings-snapshot/616-23bd561b-ebd9-447b-a698-a4ea10e2f9e9", "date": "2026-04-23", "summary": "Thermo Fisher Scientific Inc. reported first-quarter net income of $1.65 billion, or $4.43 per share. Adjusted earnings of $5.44 per share surpassed Wall Street expectations of $5.20 per share. The company also exceeded revenue forecasts, posting $11.01 billion against an expected $10.83 billion.", "sentiment_score": 0.41441, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Global Cloud ELN Service Market | USA, China, India Lead | Thermo Fisher Scientific, Agilent Technologies, Dassault Systèmes Drive Digital Lab Transformation", "url": "https://www.bolsamania.com/nota-de-prensa/mercados/global-cloud-eln-service-market-usa-china-india-lead-thermo-fisher-scientific-agilent-technologies-dassault-systemes-drive-digital-lab-transformation--22333068.html", "date": "2026-04-22", "summary": "The global Cloud Electronic Laboratory Notebook (ELN) Service market is poised for significant growth, projected to reach USD 1,156.0 million by 2035 from USD 375.1 million in 2025, driven by digital transformation in research, regulatory compliance needs, and demand for collaborative data management. Key growth regions include India, China, and the USA, with leading companies like Thermo Fisher Scientific, Agilent Technologies, and Dassault Systèmes spearheading this digital laboratory evolutio", "sentiment_score": 0.746394, "sentiment_label": "Bullish", "relevance_score": 0.895904, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Global Cloud ELN Service Market | USA, China, India Lead | Thermo Fisher Scientific, Agilent Technologies, Dassault Systèmes Drive Digital Lab Transformation", "url": "https://sg.finance.yahoo.com/news/global-cloud-eln-market-usa-155700233.html", "date": "2026-04-22", "summary": "The global Cloud ELN Service market is experiencing strong growth, projected to reach USD 1,156.0 million by 2035 from USD 375.1 million in 2025, driven by digital transformation, regulatory compliance, and increased demand for collaborative data management. Key players like Thermo Fisher Scientific, Agilent Technologies, and Dassault Systèmes are leading this sector, with software and cloud-based deployment being the dominant and fastest-growing segments. India, China, and the USA are identifie", "sentiment_score": 0.504853, "sentiment_label": "Bullish", "relevance_score": 0.944071, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "HiFi multiomics reveals how biology shapes life on Earth", "url": "https://www.pacb.com/blog/hifi-multiomics-reveals-how-biology-shapes-life-on-earth/", "date": "2026-04-22", "summary": "On Earth Day 2026, PacBio highlights how HiFi multiomic approaches are revolutionizing the understanding of biology across the planet. Recent studies using HiFi sequencing are revealing the intricate details of genomes, their function, adaptation, and interaction with environments. The article details multiomic investigations into somatic and germline mutations, chromosome-scale assemblies, epigenome mapping, transcriptome resolution, and microbial diversity, showcasing how these technologies ar", "sentiment_score": 0.278729, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.602714, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Gene Expression Analysis Market Set for Robust Growth to USD 11.25 Billion by 2033, Driven by Precision Medicine and Genomics Advancements, with Thermo Fisher Scientific Inc., Illumina Inc., and QIAGEN N.V. Leading the Competitive Landscape", "url": "https://www.openpr.com/news/4483981/gene-expression-analysis-market-set-for-robust-growth-to-usd", "date": "2026-04-22", "summary": "The global Gene Expression Analysis Market is projected to reach USD 11.25 billion by 2033, growing at an 8.7% CAGR from USD 5.78 billion in 2025. This growth is driven by the increasing adoption of advanced genomic technologies in life sciences and healthcare, especially for precision medicine, biomarker discovery, and diagnostics. Key players like Thermo Fisher Scientific, Illumina, and QIAGEN are leading the market with advancements in sequencing, PCR, and bioinformatics.", "sentiment_score": 0.411832, "sentiment_label": "Bullish", "relevance_score": 0.96297, "sentiment": { "label": "positive", "score": 0.691, "confidence": 0.69 } }, { "source": "alpha_vantage", "title": "WST Likely to Beat Q1 Earnings Estimates: How to Play the Stock?", "url": "https://www.tradingview.com/news/zacks:d4a6d61b4094b:0-wst-likely-to-beat-q1-earnings-estimates-how-to-play-the-stock/", "date": "2026-04-21", "summary": "West Pharmaceutical Services (WST) is expected to surpass its first-quarter 2026 earnings estimates, with anticipated revenues between $770-$790 million and adjusted diluted EPS of $1.65-$1.70. The company's strong operational momentum, driven by its high-value product portfolio and GLP-1 demand, positions it for continued growth. With a positive Earnings ESP and a Zacks Rank #3, WST is predicted for an earnings beat.", "sentiment_score": 0.509265, "sentiment_label": "Bullish", "relevance_score": 0.612897, "sentiment": { "label": "positive", "score": 0.34, "confidence": 0.34 } }, { "source": "alpha_vantage", "title": "Metagenomics Market Key Companies Analysis - Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies, Qiagen, Bio-Rad Laboratories, Inc., Perkinelmer Inc., Illumina Inc. etc.", "url": "https://www.openpr.com/news/4482480/metagenomics-market-key-companies-analysis-merck-kgaa-thermo", "date": "2026-04-21", "summary": "The global metagenomics market continues its significant growth, driven by advancements in sequencing technologies, declining costs, and increasing applications across healthcare, biotechnology, agriculture, and environmental studies. Valued at US$ 165.8 million in 2018, it is projected to reach US$ 314.3 million by 2027, with a CAGR of 7.7%. Key players like Merck KGaA, Thermo Fisher Scientific, and Illumina Inc. are spearheading innovations, despite challenges such as high capital investment a", "sentiment_score": 0.039804, "sentiment_label": "Neutral", "relevance_score": 0.342502, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Revvity Inc. stock (US76155R1086): Why does its life sciences focus matter more for U.S. investors n", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/revvity-inc-stock-us76155r1086-why-does-its-life-sciences-focus-matter/69230275", "date": "2026-04-21", "summary": "Revvity Inc. (US76155R1086) is highlighted as a key player in life sciences discovery and diagnostics, offering stability and growth potential for U.S. investors due to its focus on essential technologies for drug development, genetic research, and clinical diagnostics. The company's business model, which provides high-precision instruments and recurring revenue streams from consumables and services, positions it well within the accelerating healthcare R&D sector. Analysts generally have a posit", "sentiment_score": -0.122284, "sentiment_label": "Neutral", "relevance_score": 0.633041, "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "alpha_vantage", "title": "Avantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing", "url": "https://www.stocktitan.net/news/AVTR/avantor-unifies-masterflex-portfolio-to-streamline-fluid-management-qe2ssxkrxb25.html", "date": "2026-04-21", "summary": "Avantor has unified its Masterflex fluid handling portfolio, now encompassing standard, configurable, and engineered-to-order peristaltic pumps, single-use assemblies, and systems. This expansion is designed to streamline fluid management from R&D to high-volume bioprocess manufacturing, including new PROFINET connectivity and storage containers. Avantor will showcase these integrated systems and provide a technical presentation at INTERPHEX 2026 in New York.", "sentiment_score": 0.127583, "sentiment_label": "Neutral", "relevance_score": 0.627374, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Automated Cell Culture Market Is Going to Boom |• Thermo Fisher Scientific • Merck KGaA", "url": "https://www.openpr.com/news/4482085/automated-cell-culture-market-is-going-to-boom-thermo-fisher", "date": "2026-04-21", "summary": "Worldwide Market Reports (WMR) has published an in-depth study on the \"Automated Cell Culture Market Size and Forecast 2026-2033.\" The report provides a data-driven analysis of historical trends and future projections for the global market, highlighting growth drivers, opportunities, risks, and challenges. It includes SWOT analysis, Porter's Five Forces framework, regional performance, and profiles of key industry players such as Thermo Fisher Scientific and Merck KGaA.", "sentiment_score": 0.403375, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Saladax Biomedical and Thermo Fisher Scientific Partner on Global Distribution of Drug Monitoring Assays", "url": "https://clpmag.com/lab-management/company-news/saladax-thermo-fisher-distribution-drug-monitoring-assays/", "date": "2026-04-21", "summary": "Saladax Biomedical and Thermo Fisher Scientific have formed a distribution agreement to globally expand access to therapeutic drug monitoring (TDM) assays for psychiatry and oncology patients. This partnership aims to increase the availability of TDM tests which run on existing laboratory equipment, allowing clinicians to tailor therapy, reduce toxicity, and improve patient outcomes by providing rapid drug concentration measurements. The collaboration leverages Thermo Fisher's distribution chann", "sentiment_score": 0.44217, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "TD Cowen Lowers Thermo Fisher (TMO) Price Target, Keeps Buy Rating", "url": "https://www.insidermonkey.com/blog/td-cowen-lowers-thermo-fisher-tmo-price-target-keeps-buy-rating-1742669/", "date": "2026-04-21", "summary": "TD Cowen has lowered its price target on Thermo Fisher Scientific (TMO) from $683 to $625 but maintained a Buy rating. The firm raised its Q1 EPS estimate to match company guidance, which anticipates 1% organic growth despite negative impacts. TD Cowen expects Q1 to be the low point for EPS growth, with stronger organic growth accelerating in the second half of 2026 due to pharma strength and potential preclinical improvements.", "sentiment_score": 0.133768, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.128, "confidence": 0.13 } }, { "source": "alpha_vantage", "title": "TD Cowen Lowers Thermo Fisher (TMO) Price Target, Keeps Buy Rating", "url": "https://uk.finance.yahoo.com/news/td-cowen-lowers-thermo-fisher-105322432.html", "date": "2026-04-21", "summary": "TD Cowen has lowered its price target on Thermo Fisher Scientific Inc. (NYSE:TMO) from $683 to $625 while maintaining a Buy rating. The firm raised its Q1 EPS estimate to $5.21 and expects 1% organic growth for the quarter, despite a negative impact from one less day and a customer shutdown. TD Cowen anticipates Q1 to be the low point for EPS growth, with stronger organic growth accelerating in the second half of 2026 driven by pharma strength and preclinical improvements.", "sentiment_score": 0.114291, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.128, "confidence": 0.13 } }, { "source": "alpha_vantage", "title": "Danaher lifts 2026 profit outlook after $6 billion first quarter", "url": "https://www.stocktitan.net/news/DHR/danaher-reports-first-quarter-2026-mqqa9t2hhl70.html", "date": "2026-04-21", "summary": "Danaher Corporation reported first-quarter 2026 net earnings of $1.0 billion on revenues of $6.0 billion, a 3.5% increase year-over-year. The company's non-GAAP adjusted diluted EPS grew 9.5% to $2.06, leading to a raised full-year adjusted EPS guidance to $8.35–$8.55. Danaher also announced its intention to acquire Masimo Corporation, aiming to enhance its patient monitoring capabilities.", "sentiment_score": 0.202263, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.562883, "sentiment": { "label": "positive", "score": 0.64, "confidence": 0.64 } }, { "source": "alpha_vantage", "title": "AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth", "url": "https://finance.yahoo.com/markets/stocks/articles/axogen-axgn-reports-next-week-140018404.html", "date": "2026-04-21", "summary": "AxoGen (AXGN) is projected to report a significant year-over-year increase in earnings and higher revenues for the quarter ended March 2026, with an expected earnings per share of $0.12 and revenues of $58.7 million. The company has a positive Earnings ESP of +16.67% and a Zacks Rank of #3 (Hold), suggesting a high probability of beating consensus EPS estimates. Investors are advised to consider other factors beyond earnings when making investment decisions.", "sentiment_score": 0.30912, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.643158, "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } }, { "source": "alpha_vantage", "title": "Residual DNA Testing Market is Going to Boom| Thermo Fisher Scientific, QIAGEN, Illumina, and Agilent Technologies", "url": "https://www.openpr.com/news/4481526/residual-dna-testing-market-is-going-to-boom-thermo-fisher", "date": "2026-04-21", "summary": "The Residual DNA Testing Market is projected for strong growth between 2026 and 2033, driven by rising demand and continuous innovation. A new research report provides in-depth analysis of market size, revenue performance, production trends, and CAGR projections, identifying key players such as Thermo Fisher Scientific, QIAGEN, and Illumina. The report covers market dynamics, segmentation, competitive landscape, and geographical trends, offering strategic insights for industry leaders.", "sentiment_score": 0.40512, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "SLS Stock Jumps Premarket: US Investor Dagco Boosts Stake By 78% Ahead Of Fresh Cancer Drug Data Reveal", "url": "https://stocktwits.com/news-articles/markets/equity/sls-stock-premarket-dagco-raises-stake-ahead-of-aacr-leukemia-data/cZBIfhbRICL", "date": "2026-04-21", "summary": "Sellas Life Sciences Group (SLS) saw its stock jump premarket after investor Dagco increased its stake by 78%, making Sellas its second-largest holding. This boost comes ahead of new preclinical data for Sellas's cancer drug SLS009 targeting acute myeloid leukemia (AML) at the AACR conference and as its Phase 3 Regal trial for GPS nears topline analysis. The stock has surged over 280% in the past year, reflecting strong investor interest in its pipeline.", "sentiment_score": 0.106038, "sentiment_label": "Neutral", "relevance_score": 0.642371, "sentiment": { "label": "negative", "score": -0.202, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Qiagen N.V. stock (NL0012169213): Is its diagnostics dominance strong enough to unlock new upside?", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/qiagen-n-v-stock-nl0012169213-is-its-diagnostics-dominance-strong/69227169", "date": "2026-04-21", "summary": "Qiagen N.V. is a leader in molecular diagnostics, offering tools for genetic material detection and analysis, vital for genomic research and personalized medicine. The company's \"sample to insight\" model, relying on high-margin consumables and automation, provides a stable revenue stream and positions it for growth in areas like liquid biopsies and companion diagnostics. While facing competition from giants like Thermo Fisher and Roche, Qiagen's strong IP, strategic acquisitions, and global dist", "sentiment_score": 0.13797, "sentiment_label": "Neutral", "relevance_score": 0.641114, "sentiment": { "label": "positive", "score": 0.625, "confidence": 0.62 } }, { "source": "alpha_vantage", "title": "Assessing Thermo Fisher Scientific (TMO) Valuation After New PCR Launch And Data Partnerships", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/assessing-thermo-fisher-scientific-tmo-valuation-after-new-p", "date": "2026-04-21", "summary": "Thermo Fisher Scientific (TMO) has introduced a new PCR instrument and formed data-driven partnerships, leading to mixed stock performance. While the company's valuation is considered 2.6% undervalued at $540.27 according to one narrative, future growth depends on R&D budgets, successful M&A integration, and demand for its tools. Investors are advised to consider the full picture, including potential risks, before making investment decisions.", "sentiment_score": 0.289388, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Revvity Inc. stock (US76155R1086): Is its life sciences focus strong enough to drive steady investor", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/revvity-inc-stock-us76155r1086-is-its-life-sciences-focus-strong/69223498", "date": "2026-04-21", "summary": "Revvity Inc. (US76155R1086) provides tools for drug discovery and diagnostics, positioning it in the life sciences sector with robust demand. The company's core business model focuses on precision tools for research and diagnostics, emphasizing recurring revenue from consumables and services. Revvity aims for long-term growth through strategic investments in high-growth areas like cell and gene therapy, digital integration, and global expansion, while facing risks from biopharma budget cuts and ", "sentiment_score": 0.130637, "sentiment_label": "Neutral", "relevance_score": 0.671617, "sentiment": { "label": "positive", "score": 0.511, "confidence": 0.51 } }, { "source": "alpha_vantage", "title": "Qiagen N.V. stock (NL0012169213): Why does its molecular diagnostics edge matter more for U.S. investors now?", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/qiagen-n-v-stock-nl0012169213-why-does-its-molecular-diagnostics-edge/69221736", "date": "2026-04-20", "summary": "The article highlights Qiagen N.V.'s strategic position in the molecular diagnostics market, emphasizing its \"sample-to-insight\" technology as a stable investment opportunity for U.S. and English-speaking investors. It details how Qiagen's focus on enabling technologies, rather than direct drug development, provides exposure to booming biotech demand with lower volatility and reduced R&D risks. The company's core business model, key growth drivers, competitive advantage, and relevance for intern", "sentiment_score": -0.135737, "sentiment_label": "Neutral", "relevance_score": 0.647903, "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "alpha_vantage", "title": "OpenAI debuts AI model GPT-Rosalind to speed up drug discovery", "url": "https://www.techtarget.com/pharmalifesciences/news/366641922/OpenAI-debuts-AI-model-GPT-Rosalind-to-speed-up-drug-discovery", "date": "2026-04-20", "summary": "OpenAI has launched \"GPT-Rosalind,\" its first AI model designed to accelerate early-stage research in drug discovery, biology, and translational medicine. Named after Rosalind Franklin, the model combines advanced reasoning with integration across scientific tools and databases. Several biopharma companies, including Moderna and Amgen, are collaborating with OpenAI to incorporate GPT-Rosalind into their R&D workflows.", "sentiment_score": 0.329383, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.718316, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Danaher Corp. stock (US2358511028): Is its life sciences dominance strong enough to unlock new upsid", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/danaher-corp-stock-us2358511028-is-its-life-sciences-dominance-strong/69219197", "date": "2026-04-20", "summary": "Danaher operates as a science and technology leader focused on life sciences, diagnostics, and environmental solutions, utilizing an acquisition strategy to drive growth. The company's diverse portfolio and strategic initiatives like significant R&D investment and continuous improvement through its DPS operating system position it as a resilient investment amidst industry shifts. Despite potential risks like R&D budget cuts and competitive threats, analysts maintain a positive outlook due to Dan", "sentiment_score": 0.124145, "sentiment_label": "Neutral", "relevance_score": 0.60254, "sentiment": { "label": "positive", "score": 0.625, "confidence": 0.62 } }, { "source": "alpha_vantage", "title": "Thermo Fisher: Great Business Still Trading At A Risky Price Before Earnings (NYSE:TMO)", "url": "https://seekingalpha.com/article/4892026-thermo-fisher-great-business-still-trading-at-a-risky-price-before-earnings", "date": "2026-04-20", "summary": "Thermo Fisher Scientific (TMO) is a high-quality business but is currently overvalued given its growth outlook. With FY25 revenue growth of 3.9% and EPS growth of 7.3%, and a FY26 adjusted EPS growth guidance of 6-8%, the stock's near 30x earnings/free cash flow valuation seems stretched without a return to double-digit growth. The author maintains a Hold rating, citing fair-to-rich valuation and potential risks like funding pressures and macroeconomic instability.", "sentiment_score": 0.077964, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.511, "confidence": 0.51 } }, { "source": "alpha_vantage", "title": "Here's How Much $100 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth Today", "url": "https://www.benzinga.com/insights/news/26/04/51916651/heres-how-much-100-invested-in-thermo-fisher-scientific-20-years-ago-would-be-worth-today", "date": "2026-04-20", "summary": "Investing $100 in Thermo Fisher Scientific (NYSE: TMO) 20 years ago would yield $1,368.27 today, demonstrating the power of compounded returns. Over two decades, TMO has outperformed the market with an average annual return of 13.91%. The company currently holds a market capitalization of $198.89 billion.", "sentiment_score": 0.339774, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.226, "confidence": 0.23 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Launches Applied Biosystems PowerFlex Thermal Cycler for Advanced PCR Workflows", "url": "https://www.digitalhealthnews.com/thermo-fisher-scientific-launches-applied-biosystems-powerflex-thermal-cycler-for-advanced-pcr-workflows-", "date": "2026-04-20", "summary": "Thermo Fisher Scientific has introduced the Applied Biosystems PowerFlex Thermal Cycler, a new PCR system designed to enhance efficiency in molecular biology labs. This instrument offers increased flexibility, precise thermal control, and improved productivity, addressing the growing complexity of testing and the need for shared instrument usage. It is engineered for faster run times, ensuring accuracy and reproducibility across various applications, from life science research to clinical testin", "sentiment_score": 0.483527, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.25, "confidence": 0.25 } }, { "source": "alpha_vantage", "title": "Biodesix to highlight novel diagnostic test discovery and pipeline development at AACR 2026", "url": "https://www.selectscience.net/article/biodesix-to-highlight-novel-diagnostic-test-discovery-and-pipeline-development-at-aacr-2026", "date": "2026-04-20", "summary": "Biodesix, Inc. will present seven abstracts, including two oral sessions, at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, USA. The presentations will cover Biodesix's capabilities in blood- and tissue-based cancer testing and monitoring, highlighting their expertise in tumor and immune profiling using various advanced platforms. Additionally, the company will showcase a novel multi-omic approach to molecular residual disease (MRD) monitoring, featuring collabo", "sentiment_score": 0.240603, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.749059, "sentiment": { "label": "positive", "score": 0.572, "confidence": 0.57 } }, { "source": "sec", "filing_type": "8-K", "title": "8-K - Current report", "date": "2026-04-23", "url": "https://www.sec.gov/Archives/edgar/data/97745/000009774526000086/0000097745-26-000086-index.htm", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Central Nervous System (CNS) Biomarkers Global Market Analysis Report 2026: Focus on Alzheimer's, Multiple Sclerosis, ALS, Frontotemporal Dementia, Parkinson's Disease - Forecast to 2030", "description": "Key market opportunities in the CNS Biomarkers sector include utilizing AI and technologies like ML and NLP to enhance drug development, improve patient stratification, and optimize medication strategies. Focus areas include neurodegenerative diseases and per…", "url": "https://www.globenewswire.com/news-release/2026/04/23/3279653/28124/en/Central-Nervous-System-CNS-Biomarkers-Global-Market-Analysis-Report-2026-Focus-on-Alzheimer-s-Multiple-Sclerosis-ALS-Frontotemporal-Dementia-Parkinson-s-Disease-Forecast-to-2030.html", "date": "2026-04-23", "published_at": "2026-04-23T09:45:00Z", "sentiment": { "label": "positive", "score": 0.844, "confidence": 0.84 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "2025 Protein Synthesis Research Review and Global Market Forecasts to 2030", "description": "Opportunities lie in the expanding demand for protein therapeutics driven by chronic disease prevalence, advancements in cell-free systems, and personalized medicine. Growth is supported by companies enhancing efficiency through R&D in protein synthesis, desp…", "url": "https://www.globenewswire.com/news-release/2026/04/23/3279646/28124/en/2025-Protein-Synthesis-Research-Review-and-Global-Market-Forecasts-to-2030.html", "date": "2026-04-23", "published_at": "2026-04-23T09:16:00Z", "sentiment": { "label": "positive", "score": 0.818, "confidence": 0.82 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "2025 Diagnostics Market Research Review Report", "description": "Emerging markets and rising healthcare expenditures drive demand for advanced diagnostic tools. Opportunities include personalized medicine, AI investments, and non-oncology applications, with a focus on value-based healthcare and low-cost home care technolog…", "url": "https://www.globenewswire.com/news-release/2026/04/23/3279640/28124/en/2025-Diagnostics-Market-Research-Review-Report.html", "date": "2026-04-23", "published_at": "2026-04-23T09:07:00Z", "sentiment": { "label": "positive", "score": 0.743, "confidence": 0.74 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Cancer Biomarkers Market Research Report 2026: Asia Pacific is a High-potential Region Fueled by Increased Healthcare Spending, While Genetic and Epigenetic Segments Drive Innovation", "description": "Emerging opportunities in the cancer biomarkers market include the growth of personalized oncology, non-invasive diagnostics, and omics technologies. The Asia Pacific is a high-potential region fueled by increased healthcare spending, while genetic and epigen…", "url": "https://www.globenewswire.com/news-release/2026/04/23/3279611/28124/en/Cancer-Biomarkers-Market-Research-Report-2026-Asia-Pacific-is-a-High-potential-Region-Fueled-by-Increased-Healthcare-Spending-While-Genetic-and-Epigenetic-Segments-Drive-Innovation.html", "date": "2026-04-23", "published_at": "2026-04-23T08:02:00Z", "sentiment": { "label": "positive", "score": 0.252, "confidence": 0.25 } }, { "source": "news", "source_name": "Nature.com", "title": "TBL1X/TBL1XR1 govern β-cell identity through a PAX6-containing gene regulatory network", "description": "Here they identify TBL/R1 as regulator of insulin levels and pancreatic β-cell identity. Mice with β-cell TBL/R1 deficiency display diabetes and interactome screens reveal a regulatory network including PAX6, verified in human β-cells.", "url": "https://www.nature.com/articles/s41467-026-72077-5", "date": "2026-04-23", "published_at": "2026-04-23T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Barchart.com", "title": "Stocks Settle Higher as Nasdaq Posts a Record High on Tech Strength", "description": "The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed up +1.05%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.69%, and the Nasdaq 100 Index (...", "url": "https://www.barchart.com/story/news/1459130/stocks-settle-higher-as-nasdaq-posts-a-record-high-on-tech-strength", "date": "2026-04-22", "published_at": "2026-04-22T20:35:34Z", "sentiment": { "label": "positive", "score": 0.494, "confidence": 0.49 } }, { "source": "news", "source_name": "Yahoo Entertainment", "title": "Thermo Fisher (TMO) Q4 2024 Earnings Transcript", "description": "", "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_08483f41-cb08-42e2-860b-aa00c634ddb6", "date": "2026-04-22", "published_at": "2026-04-22T19:58:20Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "BleepingComputer", "title": "Spain dismantles major $4.7M manga piracy platform, arrests four", "description": "The Spanish police have dismantled the largest Spanish-language manga piracy platform, operating since 2014, with millions of monthly users from around the globe. [...]", "url": "https://www.bleepingcomputer.com/news/security/spain-dismantles-major-47m-manga-piracy-platform-arrests-four/", "date": "2026-04-22", "published_at": "2026-04-22T15:06:34Z", "sentiment": { "label": "negative", "score": -0.44, "confidence": 0.44 } }, { "source": "news", "source_name": "Plos.org", "title": "In vivo mouse model of calcific myonecrosis induced by injury", "description": "Skeletal muscle is the major tissue that provides a space and source for bone, which is formed by osteoblasts through the secretion of extracellular matrices, such as type I collagen, and the deposition of hydroxyapatite calcium phosphate crystals. In the pre…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0346816", "date": "2026-04-22", "published_at": "2026-04-22T14:00:00Z", "sentiment": { "label": "negative", "score": -0.421, "confidence": 0.42 } }, { "source": "news", "source_name": "Plos.org", "title": "Antitumoral immunity induced by gel ethanol ablation to treat unresectable colorectal cancer metastases in the liver", "description": "Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide. A quarter of CRC patients develop liver metastases. Treatment options for liver metastases include surgically removing the tumors or undergoing liver transplantation; howe…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347625", "date": "2026-04-22", "published_at": "2026-04-22T14:00:00Z", "sentiment": { "label": "negative", "score": -0.796, "confidence": 0.8 } }, { "source": "news", "source_name": "Plos.org", "title": "Structure of the human P2X3 receptor reveals the basis for subtype-selective inhibition by sivopixant", "description": "P2X receptors are membrane ion channels that are targets for treating chronic pain and cough, motivating efforts to develop subtype-selective negative allosteric modulators (NAMs). This study solves the cryo-EM structure of the human P2X3 receptor in complex …", "url": "https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003777", "date": "2026-04-22", "published_at": "2026-04-22T14:00:00Z", "sentiment": { "label": "negative", "score": -0.637, "confidence": 0.64 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Coagulation Analyzer Market Size to Reach a Valuation of USD 7.87 Billion by 2035; Increasing Incidence of Blood Disorders to Propel Market Expansion Globally | SNS Insider", "description": "Coagulation analyzer market grows with rising CVD, surgeries, and automation demand, driven by diagnostics accuracy, and lab expansion....", "url": "https://www.globenewswire.com/news-release/2026/04/22/3279119/0/en/Coagulation-Analyzer-Market-Size-to-Reach-a-Valuation-of-USD-7-87-Billion-by-2035-Increasing-Incidence-of-Blood-Disorders-to-Propel-Market-Expansion-Globally-SNS-Insider.html", "date": "2026-04-22", "published_at": "2026-04-22T14:00:00Z", "sentiment": { "label": "negative", "score": -0.103, "confidence": 0.1 } }, { "source": "news", "source_name": "Plos.org", "title": "Nicotinamide metabolism is essential for Hepatitis C Virus replication and the production of infectious Lipo-Viro-Particles", "description": "Author summary Hepatitis C virus (HCV) produces highly infectious particles known as lipo-viro-particles (LVPs), which are characterized by an unusually high lipid content. The formation of these particles relies on the host cell’s lipid metabolism, but the m…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014165", "date": "2026-04-22", "published_at": "2026-04-22T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Plos.org", "title": "Beyond Clavulanic Acid biosynthesis: Exploring the broad regulatory impact of BldD in Streptomyces clavuligerus ATCC 27064", "description": "BldD is a global regulator of morphological development in Streptomyces, usually acting as a repressor of aerial mycelium formation. However, its role in metabolism and secondary biosynthesis in the wild-type strain Streptomyces clavuligerus remains poorly un…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347564", "date": "2026-04-22", "published_at": "2026-04-22T14:00:00Z", "sentiment": { "label": "negative", "score": -0.382, "confidence": 0.38 } }, { "source": "news", "source_name": "Plos.org", "title": "Serological evidence of Borrelia turicatae in Raccoons (Procyon lotor) from an endemic focus of tick-borne relapsing fever in Mexico", "description": "Author summary Despite being originally described in Mexico, tick-borne relapsing fever caused by Borrelia turicatae is poorly understood and understudied. Historical and recent findings show that Ornithodoros turicata is distributed from central to northwest…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014242", "date": "2026-04-22", "published_at": "2026-04-22T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Plos.org", "title": "Modeling neonatal immune response to B. pertussis identifies early B cell activation and differentiation", "description": "Author summary Pertussis disease is mainly caused by the infection of the respiratory tract by the Gram-negative bacterium Bordetella pertussis. Despite global vaccination efforts, pertussis outbreaks continue to threaten neonates and young infants who face t…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014163", "date": "2026-04-22", "published_at": "2026-04-22T14:00:00Z", "sentiment": { "label": "negative", "score": -0.103, "confidence": 0.1 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Zinc Citrate Market Size to Reach USD 3.73 Billion by 2035, Fueled by Rising Demand in Supplements and Oral Care Applications | Research by SNS Insider", "description": "The zinc citrate market is growing steadily due to its high bioavailability and low gastrointestinal irritation, driving increasing use across dietary supplements, pharmaceuticals, food fortification, and oral care products. The zinc citrate market is growing…", "url": "https://www.globenewswire.com/news-release/2026/04/22/3278774/0/en/Zinc-Citrate-Market-Size-to-Reach-USD-3-73-Billion-by-2035-Fueled-by-Rising-Demand-in-Supplements-and-Oral-Care-Applications-Research-by-SNS-Insider.html", "date": "2026-04-22", "published_at": "2026-04-22T10:30:00Z", "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "$10+ Bn Microbiology Testing Market Analysis by Product, Technology, End User - Global Forecast to 2031", "description": "The global microbiology testing market is set to reach USD 10.09 billion by 2031, growing from USD 7.79 billion in 2026 at a CAGR of 5.3%. Growth is driven by rising contamination risks in food, water, and environmental sectors, along with advances in testing…", "url": "https://www.globenewswire.com/news-release/2026/04/22/3278699/28124/en/10-Bn-Microbiology-Testing-Market-Analysis-by-Product-Technology-End-User-Global-Forecast-to-2031.html", "date": "2026-04-22", "published_at": "2026-04-22T08:24:00Z", "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Syngenta Deploys Tetra OS to Accelerate Scientific Discovery Through Industrial-Scale Data Automation", "description": "BOSTON, April 22, 2026 (GLOBE NEWSWIRE) --  TetraScience, the Scientific Data and AI Company, today announced that Syngenta has selected Tetra OS to power digital automation and data transformation in its Crop Protection R&D organization. This move is set to …", "url": "https://www.globenewswire.com/news-release/2026/04/22/3278663/0/en/Syngenta-Deploys-Tetra-OS-to-Accelerate-Scientific-Discovery-Through-Industrial-Scale-Data-Automation.html", "date": "2026-04-22", "published_at": "2026-04-22T06:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "Focal white matter lesions drive grey matter inflammation and synapse loss", "description": "A transient grey matter microgliosis is required for remyelination, the failure of which results in a chronic neuroinflammatory state seen in neurodegenerative disorders.", "url": "https://www.nature.com/articles/s41586-026-10414-w", "date": "2026-04-22", "published_at": "2026-04-22T00:00:00Z", "sentiment": { "label": "negative", "score": -0.799, "confidence": 0.8 } }, { "source": "news", "source_name": "Nature.com", "title": "Astrocytes connect specific brain regions through plastic networks", "description": "Communication between distant brain regions is mediated by plastic networks of gap junction-coupled astrocytes.", "url": "https://www.nature.com/articles/s41586-026-10426-6", "date": "2026-04-22", "published_at": "2026-04-22T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "Mechanically driven Li dendrite penetration in garnet solid electrolyte", "description": "Cryogenic electron microscopy images and micromechanical fracture modelling of mechanically soft lithium dendrites fracturing hard ceramic electrolytes suggest the mechanisms driving the phenomenon as well as design implications for solid-state lithium metal …", "url": "https://www.nature.com/articles/s41586-026-10415-9", "date": "2026-04-22", "published_at": "2026-04-22T00:00:00Z", "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "news", "source_name": "Nature.com", "title": "Dynamics of genetic and somatic trade-offs in ageing and mortality", "description": "Mapping DNA variants that modulate mortality using a starting population of 6,438 young mice defined 29 distinct loci that influence lifespan and mortality with divergent age- and sex-specific effects, as well as 30 loci that&nbs…", "url": "https://www.nature.com/articles/s41586-026-10407-9", "date": "2026-04-22", "published_at": "2026-04-22T00:00:00Z", "sentiment": { "label": "positive", "score": 0.294, "confidence": 0.29 } }, { "source": "news", "source_name": "Nature.com", "title": "Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer", "description": "The Lap-NET1 phase 1b trial reports that combined netrin1 antibody (NP137) plus modified FOLFIRINOX therapy on patients with locally advanced pancreatic cancer was well tolerated and improved progression-free survival and overall survival via inhibition of ep…", "url": "https://www.nature.com/articles/s41586-026-10436-4", "date": "2026-04-22", "published_at": "2026-04-22T00:00:00Z", "sentiment": { "label": "negative", "score": -0.727, "confidence": 0.73 } }, { "source": "news", "source_name": "Nature.com", "title": "Electronic origin of reorganization energy in interfacial electron transfer", "description": "By tuning graphene’s electronic density of states, the study shows electrode electronic structure—not just the electrolyte—dominates reorganization energy and thus controls outer-sphere electron-transfer rates at solid–liquid interfaces.", "url": "https://www.nature.com/articles/s41586-026-10311-2", "date": "2026-04-22", "published_at": "2026-04-22T00:00:00Z", "sentiment": { "label": "positive", "score": 0.494, "confidence": 0.49 } }, { "source": "news", "source_name": "Nature.com", "title": "Myosin forces remodel F-actin for mechanosensitive protein recognition", "description": "Structural studies demonstrate that myosin generates forces that cause structural changes in actin, modulating cooperative binding by α-catenin and thus signal transduction and intercellular communication via adhesion complexes.", "url": "https://www.nature.com/articles/s41586-026-10398-7", "date": "2026-04-22", "published_at": "2026-04-22T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "H2O2 repurposes plant O2 sensing to regulate post-hypoxia responses", "description": "Experiments in Arabidopsis demonstrate that group VII ethylene response factors show differential responses to different stimuli, enabling plants in flood-prone environments to adapt to both submergence-induced hypoxia and reoxygenation upon desubmergence.", "url": "https://www.nature.com/articles/s41586-026-10366-1", "date": "2026-04-22", "published_at": "2026-04-22T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "Early fibrotic niches establish tumour-permissive microenvironments", "description": "Pathologic transformation in KrasG12D-mutant alveolar type II cells initiates a tumour-permissive niche by orchestrating epithelial, stromal and immune reprogramming through amphiregulin–EGFR signalling, creating a self-sustaining circuit critical for lung tu…", "url": "https://www.nature.com/articles/s41586-026-10399-6", "date": "2026-04-22", "published_at": "2026-04-22T00:00:00Z", "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "news", "source_name": "Plos.org", "title": "Genomic and functional adaptations in the guanylate-binding protein 5 highlight specificities of bat antiviral innate immunity", "description": "Bats harbor many zoonotic viruses yet remain asymptomatic, and the evolutionary basis of their antiviral tolerance remains unclear. This study shows that bat GBP5 evolved under positive selection, driving virus-specific restriction and lineage-specific loss o…", "url": "https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003760", "date": "2026-04-21", "published_at": "2026-04-21T14:00:00Z", "sentiment": { "label": "positive", "score": 0.221, "confidence": 0.22 } }, { "source": "news", "source_name": "Plos.org", "title": "Inducible gene deletion reveals essentiality of protein kinases and a septation initiation network in Candida albicans", "description": "Author summary Elucidating the function of essential genes in the biology of an organism is challenging, because mutants lacking an essential gene are inviable and cannot be recovered by standard methods. To investigate the importance of a set of putative ess…", "url": "https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1012118", "date": "2026-04-21", "published_at": "2026-04-21T14:00:00Z", "sentiment": { "label": "positive", "score": 0.477, "confidence": 0.48 } }, { "source": "news", "source_name": "Plos.org", "title": "Sugar, mineral, B-vitamins profiles and radical scavenging activity of Royal jelly collected at different harvesting times", "description": "Royal jelly is produced by young worker honeybees that support the growth of their larvae. Human beings can harvest and use it as functional food due to its high content of nutrients and beneficial human health effects. This study aims to investigate how harv…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347342", "date": "2026-04-21", "published_at": "2026-04-21T14:00:00Z", "sentiment": { "label": "positive", "score": 0.802, "confidence": 0.8 } }, { "source": "news", "source_name": "Plos.org", "title": "Efficacy of oxfendazole treatment against infective larvae of Litomosoides sigmodontis", "description": "Author summary Filarial worms can cause debilitating diseases and affect millions of people worldwide. New drugs are urgently needed to facilitate the elimination of filarial infections and improve the well-being and health of affected patients. Oxfendazole i…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014268", "date": "2026-04-21", "published_at": "2026-04-21T14:00:00Z", "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Zika Virus Testing Market Set to Surpass USD 480 Million by 2035 – SNS Insider", "description": "Rising Demand for Prenatal Screening and advanced molecular diagnostics Fuel a Steady 7.28% CAGR Growth Rising Demand for Prenatal Screening and advanced molecular diagnostics Fuel a Steady 7.28% CAGR Growth", "url": "https://www.globenewswire.com/news-release/2026/04/21/3277812/0/en/Zika-Virus-Testing-Market-Set-to-Surpass-USD-480-Million-by-2035-SNS-Insider.html", "date": "2026-04-21", "published_at": "2026-04-21T11:37:00Z", "sentiment": { "label": "positive", "score": 0.735, "confidence": 0.74 } }, { "source": "news", "source_name": "Yahoo Entertainment", "title": "TD Cowen Lowers Thermo Fisher (TMO) Price Target, Keeps Buy Rating", "description": "", "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_ac265b57-a631-42c7-b6da-34a37304ec67", "date": "2026-04-21", "published_at": "2026-04-21T10:53:22Z", "sentiment": { "label": "negative", "score": -0.128, "confidence": 0.13 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Biotechnology Instruments Market Analysis Report 2026-2035: Unified Frameworks Combining Genomics and Proteomics Underpin New Strategic Market Developments", "description": "The biotechnology instruments market is growing due to personalized medicine, genomics, and molecular diagnostics. Opportunities lie in integrated multi-omics platforms and automation. Challenges include high costs. North America leads the market, with key pl…", "url": "https://www.globenewswire.com/news-release/2026/04/21/3277728/28124/en/Biotechnology-Instruments-Market-Analysis-Report-2026-2035-Unified-Frameworks-Combining-Genomics-and-Proteomics-Underpin-New-Strategic-Market-Developments.html", "date": "2026-04-21", "published_at": "2026-04-21T10:12:00Z", "sentiment": { "label": "positive", "score": 0.735, "confidence": 0.74 } }, { "source": "news", "source_name": "Nature.com", "title": "Laser-induced nucleation of magnetic hopfions", "description": "The creation of stable and isolated magnetic hopfions—three-dimensional topological solitons—has remained experimentally challenging. Now the laser-induced nucleation of hopfions has been achieved in a chiral magnet.", "url": "https://www.nature.com/articles/s41567-026-03236-0", "date": "2026-04-21", "published_at": "2026-04-21T00:00:00Z", "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Global Continuous Emission Monitoring Systems Market Size/Share Worth USD 9.67 Billion by 2035 at a 9.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)", "description": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Continuous Emission Monitoring Systems Market size & share revenue was valued at approximately USD 4.02 Billion in 2025 and is e…", "url": "https://www.globenewswire.com/news-release/2026/04/20/3277389/0/en/Global-Continuous-Emission-Monitoring-Systems-Market-Size-Share-Worth-USD-9-67-Billion-by-2035-at-a-9-2-CAGR-Custom-Market-Insights-Analysis-Outlook-Leaders-Report-Trends-Forecast-.html", "date": "2026-04-20", "published_at": "2026-04-20T19:30:00Z", "sentiment": { "label": "positive", "score": 0.796, "confidence": 0.8 } }, { "source": "news", "source_name": "The Irish Times", "title": "Owen Doyle: When did it become okay for referees to address players like old chums?", "description": "Andrew Brace was the latest official to adopt this soft approach. Trust me, it’s a waste of breath", "url": "https://www.irishtimes.com/sport/rugby/2026/04/20/owen-doyle-when-did-it-become-okay-for-rugby-referees-to-address-players-like-old-chums/", "date": "2026-04-20", "published_at": "2026-04-20T17:25:57Z", "sentiment": { "label": "positive", "score": 0.681, "confidence": 0.68 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Arrayed CRISPR Screening Market Presents Lucrative Opportunities Through 2026-2030: Total Revenue to Grow by $1.64 Billion at 17.7% CAGR", "description": "Industry poised for growth, driven by advancements in precision drug discovery, rising gene therapy investments, and personalized medicine adoption Industry poised for growth, driven by advancements in precision drug discovery, rising gene therapy investments…", "url": "https://www.globenewswire.com/news-release/2026/04/20/3277327/28124/en/Arrayed-CRISPR-Screening-Market-Presents-Lucrative-Opportunities-Through-2026-2030-Total-Revenue-to-Grow-by-1-64-Billion-at-17-7-CAGR.html", "date": "2026-04-20", "published_at": "2026-04-20T16:35:00Z", "sentiment": { "label": "positive", "score": 0.869, "confidence": 0.87 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Cell Free Expression Industry Set to Reach USD 627 Million by 2035 - Investment in Cell Free Systems Surpasses USD 8 Billion in Last Six Years", "description": "The cell free expression market presents significant opportunities in developing diverse biomolecules, driven by demand from pharmaceutical and biotech sectors The cell free expression market presents significant opportunities in developing diverse biomolecul…", "url": "https://www.globenewswire.com/news-release/2026/04/20/3277317/28124/en/Cell-Free-Expression-Industry-Set-to-Reach-USD-627-Million-by-2035-Investment-in-Cell-Free-Systems-Surpasses-USD-8-Billion-in-Last-Six-Years.html", "date": "2026-04-20", "published_at": "2026-04-20T16:26:00Z", "sentiment": { "label": "positive", "score": 0.962, "confidence": 0.96 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Single Use Bioprocessing Markets and Competition Insights Report 2026 - Industry Set to Triple in Value by 2035, Reaching USD 15.5 Billion", "description": "The single-use bioprocessing market offers significant growth opportunities, driven by the demand for enhanced productivity, flexibility, and cost-efficiency. Asia-Pacific is emerging as a key growth region. The single-use bioprocessing market offers signific…", "url": "https://www.globenewswire.com/news-release/2026/04/20/3277301/28124/en/Single-Use-Bioprocessing-Markets-and-Competition-Insights-Report-2026-Industry-Set-to-Triple-in-Value-by-2035-Reaching-USD-15-5-Billion.html", "date": "2026-04-20", "published_at": "2026-04-20T16:07:00Z", "sentiment": { "label": "positive", "score": 0.914, "confidence": 0.91 } }, { "source": "news", "source_name": "Plos.org", "title": "Prion propagation is controlled by a hierarchical network involving the nuclear Tfap2c and hnRNP K factors and the cytosolic mTORC1 complex", "description": "Author summary Prion diseases are fatal brain disorders caused by misfolded forms of the cellular prion protein known as prions. Unlike most infectious agents, prions propagate by converting the normal prion protein into the misfolded form, triggering a self-…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014056", "date": "2026-04-20", "published_at": "2026-04-20T14:00:00Z", "sentiment": { "label": "negative", "score": -0.542, "confidence": 0.54 } }, { "source": "news", "source_name": "Plos.org", "title": "Entry, replication and innate immunity evasion of BANAL-236, a SARS-CoV-2-related bat virus, in Rhinolophus and human cells", "description": "Author summary Bats are known reservoirs for viruses that cause severe diseases in humans, such as coronaviruses and filoviruses. Bat species naturally or experimentally infected with these viruses rarely exhibit clinical symptoms, suggesting an evolved toler…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1013573", "date": "2026-04-20", "published_at": "2026-04-20T14:00:00Z", "sentiment": { "label": "negative", "score": -0.7, "confidence": 0.7 } }, { "source": "news", "source_name": "Plos.org", "title": "Systemic iron availability differentially shapes tumor and brain iron handling in a sex-dependent manner in glioblastoma", "description": "Iron is essential for normal physiological function, yet dysregulation of iron metabolism is increasingly recognized as a hallmark of cancers such as glioblastoma (GBM). Recent clinical evidence suggests that systemic iron deficiency anemia (IDA) negatively i…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347520", "date": "2026-04-20", "published_at": "2026-04-20T14:00:00Z", "sentiment": { "label": "negative", "score": -0.382, "confidence": 0.38 } }, { "source": "news", "source_name": "Plos.org", "title": "Dominance modifiers at the Arabidopsis self-incompatibility locus retain proto-miRNA features and act through non-canonical pathways", "description": "Author summary Many plants avoid self-fertilization through a system of self-incompatibility, which allows them to recognize and reject their own pollen. In plants like those in the Arabidopsis family, self-incompatibility operates through a “lock-and-key” sy…", "url": "https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1012127", "date": "2026-04-20", "published_at": "2026-04-20T14:00:00Z", "sentiment": { "label": "negative", "score": -0.153, "confidence": 0.15 } }, { "source": "news", "source_name": "Plos.org", "title": "Cadherin-11 serves as a novel receptor for Fusobacterium nucleatum adhesin FadA to exacerbate pulmonary inflammation", "description": "Author summary In this study, we investigated how Fusobacterium nucleatum, a bacterium commonly associated with periodontal disease, contributes to the worsening of pulmonary diseases such as chronic obstructive pulmonary disease (COPD). We discovered that a …", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014158", "date": "2026-04-20", "published_at": "2026-04-20T14:00:00Z", "sentiment": { "label": "negative", "score": -0.178, "confidence": 0.18 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Softgel Capsules Market Analysis Report 2025 - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030", "description": "The Global Softgel Capsules Market offers key opportunities due to rising dietary supplement demand, health awareness, and plant-based trend adoption. Increased consumer preference for preventive health and vegan products supports market growth despite high p…", "url": "https://www.globenewswire.com/news-release/2026/04/20/3277131/28124/en/Softgel-Capsules-Market-Analysis-Report-2025-Global-Industry-Size-Share-Trends-Opportunity-Forecast-2020-2030.html", "date": "2026-04-20", "published_at": "2026-04-20T13:27:00Z", "sentiment": { "label": "positive", "score": 0.906, "confidence": 0.91 } }, { "source": "news", "source_name": "Techtarget.com", "title": "OpenAI debuts AI model GPT-Rosalind to speed up drug discovery", "description": "Biopharma companies, including Moderna and Amgen, are working with OpenAI to integrate its new artificial intelligence model into their workflows to accelerate research and discovery.", "url": "https://www.techtarget.com/pharmalifesciences/news/366641922/OpenAI-debuts-AI-model-GPT-Rosalind-to-speed-up-drug-discovery", "date": "2026-04-20", "published_at": "2026-04-20T13:15:00Z", "sentiment": { "label": "positive", "score": 0.477, "confidence": 0.48 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Chemical Sensors Market Size to Grow USD 58.24 Billion by 2035 | Research by SNS Insider", "description": "Global Chemical Sensors Market Size, Share, Revenue Trends & Segmentation, By Type, Application, Technology, End Use and Region | Forecast 2035...", "url": "https://www.globenewswire.com/news-release/2026/04/20/3276886/0/en/Chemical-Sensors-Market-Size-to-Grow-USD-58-24-Billion-by-2035-Research-by-SNS-Insider.html", "date": "2026-04-20", "published_at": "2026-04-20T11:30:00Z", "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Healthcare Filtration Markets 2025-2035 with Focus on Biologics Manufacturing Featuring Alfa Laval, Asahi Kasei, Cobetter, Corning, Merck, Pall, Parker Hannifin, Sartorius, Thermo Fisher Scientific", "description": "Rapid growth in biologics is fueling the biopharmaceutical filtration market. Key opportunities include membrane filtration systems and single-use technologies, with North America and Europe leading. Innovations and mergers in filtration technologies are vita…", "url": "https://www.globenewswire.com/news-release/2026/04/20/3276830/28124/en/Healthcare-Filtration-Markets-2025-2035-with-Focus-on-Biologics-Manufacturing-Featuring-Alfa-Laval-Asahi-Kasei-Cobetter-Corning-Merck-Pall-Parker-Hannifin-Sartorius-Thermo-Fisher-S.html", "date": "2026-04-20", "published_at": "2026-04-20T10:44:00Z", "sentiment": { "label": "positive", "score": 0.837, "confidence": 0.84 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Dengue Testing Market Size to be Valued at USD 971.11 Million by 2035; Industry Growth is Driven by the Increase in Dengue Cases in Tropical and Sub-tropical Nations Globally | SNS Insider", "description": "Dengue testing market grows with rising cases, rapid diagnostics, RT-PCR adoption, and strong public health initiatives driving global demand....", "url": "https://www.globenewswire.com/news-release/2026/04/20/3276781/0/en/Dengue-Testing-Market-Size-to-be-Valued-at-USD-971-11-Million-by-2035-Industry-Growth-is-Driven-by-the-Increase-in-Dengue-Cases-in-Tropical-and-Sub-tropical-Nations-Globally-SNS-In.html", "date": "2026-04-20", "published_at": "2026-04-20T09:30:00Z", "sentiment": { "label": "positive", "score": 0.863, "confidence": 0.86 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Cell Line Characterization and Cell Line Development Market Trends and Global Forecasts 2025-2035: 200+ Biologics Entered the Market with More Than 10,000 Candidates Undergoing Clinical Assessment", "description": "Opportunities include the rising demand for innovative biologics and the increased need for diverse cell lines, including mammalian, microbial, and insect. Growing trends in outsourcing and the expanding Asia-Pacific market also present significant growth pro…", "url": "https://www.globenewswire.com/news-release/2026/04/20/3276740/28124/en/Cell-Line-Characterization-and-Cell-Line-Development-Market-Trends-and-Global-Forecasts-2025-2035-200-Biologics-Entered-the-Market-with-More-Than-10-000-Candidates-Undergoing-Clini.html", "date": "2026-04-20", "published_at": "2026-04-20T08:02:00Z", "sentiment": { "label": "positive", "score": 0.881, "confidence": 0.88 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Urology Devices Market to Reach $58.63 Billion by 2031 with Robotic Urologic Surgery Systems Projected to Expand at a 10.31% CAGR, Reports Mordor Intelligence", "description": "The urology devices market is driven by increasing prevalence of kidney stones, urinary incontinence, and prostate disorders, alongside growing adoption of minimally invasive procedures, with North America leading and Asia-Pacific emerging as a high-growth re…", "url": "https://www.globenewswire.com/news-release/2026/04/20/3276724/0/en/Urology-Devices-Market-to-Reach-58-63-Billion-by-2031-with-Robotic-Urologic-Surgery-Systems-Projected-to-Expand-at-a-10-31-CAGR-Reports-Mordor-Intelligence.html", "date": "2026-04-20", "published_at": "2026-04-20T07:17:00Z", "sentiment": { "label": "positive", "score": 0.735, "confidence": 0.74 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Viral Vectors & Plasmid DNA Manufacturing Market Size Worth USD 29.82 Bn by 2035 Growing Demand for Gene and Cell Therapies Drives the Market", "description": "The globe viral vectors & plasmid DNA manufacturing market size is expected to be lead USD 29.82 billion by 2035, increasing from USD 7.26 billion in 2025, with a strong CAGR of 15.17% from 2026 to 2035. The globe viral vectors & plasmid DNA manufacturing mar…", "url": "https://www.globenewswire.com/news-release/2026/04/20/3276715/0/en/Viral-Vectors-Plasmid-DNA-Manufacturing-Market-Size-Worth-USD-29-82-Bn-by-2035-Growing-Demand-for-Gene-and-Cell-Therapies-Drives-the-Market.html", "date": "2026-04-20", "published_at": "2026-04-20T06:26:00Z", "sentiment": { "label": "positive", "score": 0.66, "confidence": 0.66 } }, { "source": "news", "source_name": "BBC News", "title": "Ospreys hold on to deny Sharks in Bridgend", "description": "Ospreys keep slim United Rugby Championship play-off hopes alive with a tense win against Sharks in Bridgend.", "url": "https://www.bbc.com/sport/rugby-union/articles/czxr20en016o", "date": "2026-04-18", "published_at": "2026-04-18T20:49:45Z", "sentiment": { "label": "positive", "score": 0.878, "confidence": 0.88 } }, { "source": "news", "source_name": "BBC News", "title": "Cardiff stun Scarlets with late URC fightback", "description": "Cardiff kept alive their United Rugby Championship (URC) play-off hopes with a dramatic bonus-point Welsh derby comeback win against Scarlets.", "url": "https://www.bbc.com/sport/rugby-union/articles/cd0rmy4dnn7o?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-18", "published_at": "2026-04-18T18:49:46Z", "sentiment": { "label": "positive", "score": 0.931, "confidence": 0.93 } }, { "source": "news", "source_name": "BBC News", "title": "Cardiff stun Scarlets with late URC fightback", "description": "Cardiff kept alive their United Rugby Championship (URC) play-off hopes with a dramatic bonus-point Welsh derby comeback win against Scarlets.", "url": "https://www.bbc.com/sport/rugby-union/articles/cd0rmy4dnn7o", "date": "2026-04-18", "published_at": "2026-04-18T18:49:41Z", "sentiment": { "label": "positive", "score": 0.931, "confidence": 0.93 } }, { "source": "news", "source_name": "BBC News", "title": "Parsons hat-trick as Ireland thrash Italy in Galway", "description": "Beibhinn Parsons scores a hat-trick as Ireland turn on the style to thrash Italy in Galway and register their first Women's Six Nations win of the year.", "url": "https://www.bbc.com/sport/rugby-union/articles/cn0wvwddrdno?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-18", "published_at": "2026-04-18T18:43:15Z", "sentiment": { "label": "positive", "score": 0.586, "confidence": 0.59 } }, { "source": "news", "source_name": "BBC News", "title": "France cruise past Wales with second-half power show", "description": "France slip to second in the Six Nations table on points difference despite cruising to a 38-7 victory in Cardiff.", "url": "https://www.bbc.com/sport/rugby-union/articles/ce8lmn27jjno", "date": "2026-04-18", "published_at": "2026-04-18T16:52:15Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "BBC News", "title": "England score 12 tries in huge win over Scotland", "description": "Dominant England spoil Scotland's record-breaking afternoon at Murrayfield with a 12-try win which keeps them on course for another Six Nations title.", "url": "https://www.bbc.com/sport/rugby-union/articles/cwyx0lv9le4o?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-18", "published_at": "2026-04-18T14:34:25Z", "sentiment": { "label": "positive", "score": 0.872, "confidence": 0.87 } }, { "source": "news", "source_name": "BBC News", "title": "Connacht comeback stuns Stormers in Cape Town", "description": "Connacht impress as they score five tries in a 33-24 bonus-point win over the Stormers in their United Rugby Championship game at the DHL Stadium.", "url": "https://www.bbc.com/sport/rugby-union/articles/c4gxyw79wnpo?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-18", "published_at": "2026-04-18T14:11:18Z", "sentiment": { "label": "positive", "score": 0.91, "confidence": 0.91 } }, { "source": "news", "source_name": "BBC News", "title": "Connacht comeback stuns Stormers in Cape Town", "description": "Connacht impress as they score five tries in a 33-24 bonus-point win over the Stormers in their United Rugby Championship game at the DHL Stadium.", "url": "https://www.bbc.com/sport/rugby-union/articles/c4gxyw79wnpo", "date": "2026-04-18", "published_at": "2026-04-18T14:08:56Z", "sentiment": { "label": "positive", "score": 0.91, "confidence": 0.91 } }, { "source": "news", "source_name": "Decrypt", "title": "OpenAI's New AI Model Rosalind Could Shave Years Off Drug Discovery. You Probably Can't Use It", "description": "GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.", "url": "https://decrypt.co/364783/openai-gpt-rosalind-drug-discovery-life-sciences-model", "date": "2026-04-18", "published_at": "2026-04-18T13:01:03Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "BBC News", "title": "Bulls power past Dragons to boost URC play-offs bid", "description": "Play-off hopefuls Bulls climb to fifth in the United Rugby Championship by beating Dragons 47-7 in Newport.", "url": "https://www.bbc.com/sport/rugby-union/articles/cvgkky9707eo", "date": "2026-04-17", "published_at": "2026-04-17T20:39:53Z", "sentiment": { "label": "positive", "score": 0.66, "confidence": 0.66 } }, { "source": "news", "source_name": "IPWatchdog.com", "title": "Other Barks & Bites for Friday, April 17: CAFC Reverses District Court Rulings in Penile Implant Patent Case; CJEU Clarifies Scope of ‘Pastiche’ Copyright Exception; Stanford AI Index Shows Tech Gap Between U.S. And China Nearly Gone", "description": "This week in Other Barks & Bites: the Federal Circuit reverses a California district court’s denial of JMOL on trade secret and patent inventorship claims related to a cosmetic penile implant; the Senate Commerce Committee unanimously advances a bill to reaut…", "url": "https://ipwatchdog.com/?p=200592", "date": "2026-04-17", "published_at": "2026-04-17T17:30:18Z", "sentiment": { "label": "positive", "score": 0.226, "confidence": 0.23 } }, { "source": "news", "source_name": "Plos.org", "title": "Sucralose inhibited cell survival through the activation of ER stress in human endothelial progenitor cells", "description": "Sucralose, a widely utilized non-caloric sweetener, is frequently added to food and beverage products as a sugar substitute aimed at lowering energy consumption and reducing obesity-related health risks. However, epidemiological studies have indicated a possi…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347149", "date": "2026-04-17", "published_at": "2026-04-17T14:00:00Z", "sentiment": { "label": "negative", "score": -0.637, "confidence": 0.64 } }, { "source": "news", "source_name": "Plos.org", "title": "Identification and detection of genetic markers associated with antimicrobial susceptibility and evaluation of efflux pump mechanisms in Mycoplasma iowae", "description": "Mycoplasma iowae is an economically significant pathogen that causes reduced hatchability, late embryo mortality and leg deformities, chondrodystrophy and skeletal lesions in poults. While prevention is essential in the control of infection, the appropriate a…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347345", "date": "2026-04-17", "published_at": "2026-04-17T14:00:00Z", "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "news", "source_name": "Plos.org", "title": "Effects of salinity and broad-range antibiotics on oxalate production, transport, and degradation in Poecilia latipinna", "description": "Oxalate is an anion that readily binds calcium and is thought to contribute to osmoregulation. This study investigated how environmental salinity influences oxalate homeostasis in euryhaline sailfin mollies (Poecilia latipinna), with a focus on the interplay …", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347147", "date": "2026-04-17", "published_at": "2026-04-17T14:00:00Z", "sentiment": { "label": "negative", "score": -0.527, "confidence": 0.53 } }, { "source": "news", "source_name": "RTE", "title": "Six Nations: Ireland v Italy - All you need to know", "description": "Ireland host Italy in Galway in round two of the Women's Six Nations. Find out all you need to know about the game here.", "url": "https://www.rte.ie/sport/rugby/2026/0417/1568727-six-nations-ireland-v-italy-all-you-need-to-know/", "date": "2026-04-17", "published_at": "2026-04-17T11:01:40Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "BBC News", "title": "Cardiff hope for no repeat of URC play-off agony", "description": "Cardiff are hoping history will not repeat itself as they bid to finish in the United Rugby Championship play-off places.", "url": "https://www.bbc.com/sport/rugby-union/articles/cn0wp54jj5xo?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-17", "published_at": "2026-04-17T11:00:15Z", "sentiment": { "label": "positive", "score": 0.751, "confidence": 0.75 } }, { "source": "news", "source_name": "BBC News", "title": "Ospreys not giving up on URC mission impossible", "description": "Ospreys start the 15th round of United Rugby Championship matches 10 points adrift of the top eight play-off places.", "url": "https://www.bbc.com/sport/rugby-union/articles/czxr20en016o?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-17", "published_at": "2026-04-17T11:00:10Z", "sentiment": { "label": "positive", "score": 0.667, "confidence": 0.67 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "RNA Extraction and RNA Purification Research Report 2025: Market Industry Trends and Global Forecasts to 2035 - Approximately 175 Extraction Instruments Have Been Developed Across 70 Players", "description": "Key market opportunities in the RNA extraction and purification sector include the growing demand for RNA-based therapies and diagnostics, the development of user-friendly and automated kits, and the expanding academic and research activities. North America r…", "url": "https://www.globenewswire.com/news-release/2026/04/17/3275985/28124/en/RNA-Extraction-and-RNA-Purification-Research-Report-2025-Market-Industry-Trends-and-Global-Forecasts-to-2035-Approximately-175-Extraction-Instruments-Have-Been-Developed-Across-70-.html", "date": "2026-04-17", "published_at": "2026-04-17T09:03:00Z", "sentiment": { "label": "positive", "score": 0.421, "confidence": 0.42 } }, { "source": "news", "source_name": "The Next Web", "title": "OpenAI launches GPT-Rosalind, a specialised AI model for drug discovery and life sciences research", "description": "Named after the crystallographer who helped reveal the structure of DNA, GPT-Rosalind is OpenAI’s first domain-specific model series, fine-tuned for biochemistry, genomics, and protein engineering. Access is restricted to a trusted-access programme for vetted…", "url": "https://thenextweb.com/news/openai-gpt-rosalind-life-sciences-drug-discovery-ai-model/", "date": "2026-04-17", "published_at": "2026-04-17T07:51:49Z", "sentiment": { "label": "negative", "score": -0.582, "confidence": 0.58 } }, { "source": "news", "source_name": "Torrentfreak.com", "title": "Korean Rights Holders Behind Takedown of Manga Piracy Giant TuMangaOnline", "description": "The Spanish-speaking manga community was in disarray last month when TuMangaOnline, also known as ZonaTMO, suddenly disappeared. When the site's main domain was put on clienthold by its registrar, it was clear that legal pressure was mounting. Today, Korean c…", "url": "https://torrentfreak.com/korean-rights-holders-behind-takedown-of-manga-piracy-giant-tumangaonline/", "date": "2026-04-17", "published_at": "2026-04-17T07:33:25Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "pymnts.com", "title": "OpenAI Targets Pharma Giants With Purpose-Built AI Model", "description": "OpenAI has introduced an artificial intelligence model that is purpose-built for scientific research and drug discovery. The new GPT-Rosalind features improved tool use and a deeper understanding of chemistry, protein engineering and genomics, the company sai…", "url": "https://www.pymnts.com/artificial-intelligence-2/2026/openai-targets-pharma-giants-with-purpose-built-ai-model/", "date": "2026-04-17", "published_at": "2026-04-17T02:18:28Z", "sentiment": { "label": "positive", "score": 0.735, "confidence": 0.74 } }, { "source": "news", "source_name": "Nature.com", "title": "A cell-permeable nanobody to restore F508del cystic fibrosis transmembrane conductance regulator activity", "description": "Cell-permeable nanobodies overcome a major barrier to intracellular protein targeting. Franz, Rubil and colleagues show that delivery of a CFTR-binding nanobody into airway epithelial cells from patients with cystic fibrosis homozygous for the F508del-CFTR mu…", "url": "https://www.nature.com/articles/s41589-026-02199-w", "date": "2026-04-17", "published_at": "2026-04-17T00:00:00Z", "sentiment": { "label": "positive", "score": 0.104, "confidence": 0.1 } }, { "source": "news", "source_name": "Openai.com", "title": "GPT‑Rosalind for life sciences research", "description": "OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.", "url": "https://openai.com/index/introducing-gpt-rosalind/", "date": "2026-04-16", "published_at": "2026-04-16T19:24:50Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "The Times of India", "title": "OpenAI launches AI model GPT-Rosalind for life sciences research", "description": "The GPT-Rosalind, named after 20th-century British scientist Rosalind Franklin, is designed to support ‌research ⁠across biochemistry, drug ⁠discovery and translational medicine.", "url": "https://economictimes.indiatimes.com/tech/artificial-intelligence/openai-launches-ai-model-gpt-rosalind-for-life-sciences-research/articleshow/130317009.cms", "date": "2026-04-16", "published_at": "2026-04-16T19:14:03Z", "sentiment": { "label": "positive", "score": 0.402, "confidence": 0.4 } }, { "source": "news", "source_name": "Cdc.gov", "title": "Clusters of Invasive Haemophilus influenzae Type b Disease Among Adults Using Substances or Experiencing Homelessness or Housing Instability - Alaska, Oregon, and Washington, 2023─2025", "description": "This report describes two clusters of invasive of Haemophilus influenzae type b among adults with special risk factors in Alaska, Oregon, and Washington.", "url": "https://www.cdc.gov/mmwr/volumes/75/wr/mm7514a1.htm", "date": "2026-04-16", "published_at": "2026-04-16T17:00:00Z", "sentiment": { "label": "positive", "score": 0.153, "confidence": 0.15 } }, { "source": "news", "source_name": "Pypi.org", "title": "teradatamodelops 7.2.7", "description": "Python client for Teradata ModelOps (TMO)", "url": "https://pypi.org/project/teradatamodelops/7.2.7/", "date": "2026-04-16", "published_at": "2026-04-16T15:45:09Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Plos.org", "title": "Assessment of hemagglutinin-inhibition activity following influenza vaccination during the 2022–2023, 2023–2024, and 2024–2025 seasons", "description": "Seasonal influenza vaccines are available in multiple formulations including egg-based inactivated standard-dose, cell-based inactivated, recombinant, and live-attenuated. However, vaccine effectiveness and antibody responses vary by vaccine type, recipient a…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347314", "date": "2026-04-16", "published_at": "2026-04-16T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Plos.org", "title": "Genomic diversity analysis enables development of pan-Dengue Toehold RNA sensors", "description": "Author summary RNA viruses show high rates of sequence mutations, helping them evolve rapidly to evade the host immune system. This confounds diagnosis through detection tests where specific fragments from the viral genome are detected through designer sensor…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014173", "date": "2026-04-16", "published_at": "2026-04-16T14:00:00Z", "sentiment": { "label": "positive", "score": 0.527, "confidence": 0.53 } }, { "source": "news", "source_name": "Plos.org", "title": "PDGFRα-positive mesenchymal stem/stromal cells contribute to autonomous vascular formation through in-body tissue architecture", "description": "Driven by endogenous platelet-derived growth factor receptor α (PDGFRα)-positive cells, in-body tissue architecture (iBTA) enables the autonomous formation of vascularized tissues within subcutaneously implanted molds, overcoming the limitations of traditiona…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347197", "date": "2026-04-16", "published_at": "2026-04-16T14:00:00Z", "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } }, { "source": "news", "source_name": "Fair Observer", "title": "Donald Trump’s Racism Mirrors Jeffrey Epstein’s", "description": "Jeffrey Epstein was not only a rapist and a child predator, but also — wait for it — a white supremacist. While some speculate that the Epstein issue is just a distraction from US President Donald Trump’s virulent and endless racism, others feel that the vide…", "url": "https://www.fairobserver.com/politics/donald-trumps-racism-mirrors-jeffrey-epsteins/", "date": "2026-04-16", "published_at": "2026-04-16T13:20:24Z", "sentiment": { "label": "negative", "score": -0.938, "confidence": 0.94 } }, { "source": "news", "source_name": "BBC News", "title": "Dragons rest trio in revamped side for Bulls game", "description": "Dragons rest Wales number eight Aaron Wainwright and co-captains Angus O'Brien and Ben Carter for the URC home match against Bulls on Friday.", "url": "https://www.bbc.com/sport/rugby-union/articles/cvgkky9707eo?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-16", "published_at": "2026-04-16T11:00:35Z", "sentiment": { "label": "positive", "score": 0.077, "confidence": 0.08 } }, { "source": "news", "source_name": "Cdc.gov", "title": "Three Fatal Gestational Psittacosis Cases Caused by Chlamydia psittaci Strains Belonging to Closely Related Lineages, Japan", "description": "Fatal Gestational Psittacosis Cases, Japan", "url": "https://wwwnc.cdc.gov/eid/article/32/5/25-2008_article", "date": "2026-04-16", "published_at": "2026-04-16T04:00:00Z", "sentiment": { "label": "negative", "score": -0.848, "confidence": 0.85 } }, { "source": "news", "source_name": "Nature.com", "title": "Condensate corona–nanoparticle complexes transfer functional biomolecules between cells", "description": "After being internalized by cells, nanoparticles can, in rare events, acquire a biomolecular condensate corona. These complexes can reach the extracellular space, where they can deliver their acquired proteins and RNA content to other cells.", "url": "https://www.nature.com/articles/s41563-026-02534-5", "date": "2026-04-16", "published_at": "2026-04-16T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Healthcare Logistics Market Trends and Investment Opportunities 2026-2030 with Strategic Analysis of Key Players", "description": "Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The \"Healthcare Logistics Market 2026-2030\" has been added to ResearchAndMarkets.com's offering. The...", "url": "https://www.globenewswire.com/news-release/2026/04/15/3274741/28124/en/Healthcare-Logistics-Market-Trends-and-Investment-Opportunities-2026-2030-with-Strategic-Analysis-of-Key-Players.html", "date": "2026-04-15", "published_at": "2026-04-15T16:16:00Z", "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Animal Health Market Intelligence Report 2026-2034 Featuring Strategic Analysis of Bayer, Elanco, Merck, Merial, Zoetis, Boehringer Ingelheim, Ceva Sante Animale, Heska and More", "description": "The animal health market offers opportunities in preventive healthcare, biotechnology, and telemedicine. Rising zoonotic diseases spur demand for vaccines and diagnostics. Pet humanization drives specialized care and high-quality pet products. North America l…", "url": "https://www.globenewswire.com/news-release/2026/04/15/3274681/28124/en/Animal-Health-Market-Intelligence-Report-2026-2034-Featuring-Strategic-Analysis-of-Bayer-Elanco-Merck-Merial-Zoetis-Boehringer-Ingelheim-Ceva-Sante-Animale-Heska-and-More.html", "date": "2026-04-15", "published_at": "2026-04-15T15:16:00Z", "sentiment": { "label": "positive", "score": 0.813, "confidence": 0.81 } }, { "source": "news", "source_name": "Plos.org", "title": "NSUN4-mediated m5C RNA methylation protects retinal cells against excitotoxic injury via the SHH signaling pathway", "description": "Glaucoma, a leading global cause of blindness, is characterized by progressive retinal neuronal loss. NOP2/Sun RNA methyltransferase 4 (NSUN4), a writer of 5-methylcytosine (m5C) RNA modifications, has established roles in methylation and mitoribosome assembl…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347414", "date": "2026-04-15", "published_at": "2026-04-15T14:00:00Z", "sentiment": { "label": "negative", "score": -0.621, "confidence": 0.62 } }, { "source": "news", "source_name": "Plos.org", "title": "Circadian rhythms remain temperature compensated during a Q neuron–induced hibernation-like state in mice", "description": "The circadian clock maintains a nearly constant period across temperatures, but to what extent temperature compensation operates in mammals during deep hypothermia is unknown. This study shows that mice maintain circadian rhythms during a hibernation-like hyp…", "url": "https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003475", "date": "2026-04-15", "published_at": "2026-04-15T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Plos.org", "title": "Evaluation of therapeutic efficacy of baloxavir marboxil against high pathogenicity avian influenza virus infection in duck model", "description": "High pathogenicity avian influenza virus (HPAIV) infections have been frequently reported in wild birds since 2020. Because HPAIV infection has occasionally caused outbreaks in captive rare birds, treatment using antiviral drugs has been considered from the p…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347205", "date": "2026-04-15", "published_at": "2026-04-15T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Phosphorous Trichloride Market Size to Hit USD 4.46 Billion by 2035 | SNS Insider", "description": "The phosphorous trichloride market is growing steadily due to increasing demand for phosphorus-based intermediates in agrochemicals, pharmaceuticals, and flame retardants, supported by expanding crop protection needs and rising adoption across industrial appl…", "url": "https://www.globenewswire.com/news-release/2026/04/15/3274273/0/en/Phosphorous-Trichloride-Market-Size-to-Hit-USD-4-46-Billion-by-2035-SNS-Insider.html", "date": "2026-04-15", "published_at": "2026-04-15T10:30:00Z", "sentiment": { "label": "positive", "score": 0.361, "confidence": 0.36 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Rapid Diagnostic Tests Market Size is Expected to reach USD 67.83 Billion by 2035 Owing to the Increasing Number of Infections Globally | SNS Insider", "description": "Rapid diagnostic tests market grows with rising infections, home testing adoption, driven by tech advances, fast results, and expanding healthcare access....", "url": "https://www.globenewswire.com/news-release/2026/04/15/3274218/0/en/Rapid-Diagnostic-Tests-Market-Size-is-Expected-to-reach-USD-67-83-Billion-by-2035-Owing-to-the-Increasing-Number-of-Infections-Globally-SNS-Insider.html", "date": "2026-04-15", "published_at": "2026-04-15T09:30:00Z", "sentiment": { "label": "positive", "score": 0.103, "confidence": 0.1 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Nanotechnology Market to Grow at 13.21% CAGR to Reach USD 220.8 Billion by 2031, Supported by Healthcare Expansion and Clean Energy Initiatives, Reports Mordor Intelligence", "description": "The global nanotechnology market is driven by demand for advanced materials, expanding healthcare applications, and increasing R&D investments, with Asia-Pacific as the largest region. The global nanotechnology market is driven by demand for advanced material…", "url": "https://www.globenewswire.com/news-release/2026/04/15/3274161/0/en/Nanotechnology-Market-to-Grow-at-13-21-CAGR-to-Reach-USD-220-8-Billion-by-2031-Supported-by-Healthcare-Expansion-and-Clean-Energy-Initiatives-Reports-Mordor-Intelligence.html", "date": "2026-04-15", "published_at": "2026-04-15T07:35:00Z", "sentiment": { "label": "positive", "score": 0.883, "confidence": 0.88 } }, { "source": "news", "source_name": "Nature.com", "title": "Template-driven scaffolding of SCFFBXO42 regulates PP2A degradation", "description": "The E3 ligase SCFFBXO42 degrades holoenzyme-free PP2Ac in complex with the coiled-coil protein CCDC6 to maintain cancer cell fitness", "url": "https://www.nature.com/articles/s41586-026-10368-z", "date": "2026-04-15", "published_at": "2026-04-15T00:00:00Z", "sentiment": { "label": "negative", "score": -0.869, "confidence": 0.87 } }, { "source": "news", "source_name": "Nature.com", "title": "A series of spontaneously blinking dyes for super-resolution microscopy", "description": "A series of spontaneously blinking dyes in the far-red range facilitate single-molecule localization microscopy. These dyes vary in their blinking properties and can be matched to the applications and microscopy modalities as needed.", "url": "https://www.nature.com/articles/s41592-026-03062-5", "date": "2026-04-15", "published_at": "2026-04-15T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration", "description": "A new cerebrospinal fluid biomarker, AcTau174, was elevated in frontotemporal lobar degeneration with TAR DNA-binding protein (FTLD-TDP), distinguishing this pathology from FTLD-Tau, and was associated with disease severity and progression in FTLD-TDP.", "url": "https://www.nature.com/articles/s41591-026-04341-6", "date": "2026-04-15", "published_at": "2026-04-15T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "The neural mechanisms supporting the rise and fall of maternal aggression", "description": "In mice, female aggression is governed by an amygdala–to–medial hypothalamus circuit that is strengthened during pregnancy and is dynamically amplified by oxytocin during lactation.", "url": "https://www.nature.com/articles/s41586-026-10354-5", "date": "2026-04-15", "published_at": "2026-04-15T00:00:00Z", "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "news", "source_name": "Nature.com", "title": "Artificial allosteric protein switches with machine-learning-designed receptors", "description": "Allosteric biosensors are constructed by combining reporter proteins with machine-learning-designed receptor domains.", "url": "https://www.nature.com/articles/s41587-026-03081-9", "date": "2026-04-15", "published_at": "2026-04-15T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "42021396", "title": "Mapping of pediatric allergy structures in Italy: a nationwide survey.", "authors": "Dinardo G et al.", "journal": "Italian journal of pediatrics", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42021396/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "42018767", "title": "Heritability of Crohn's disease and ulcerative colitis: a Swedish nationwide population-based twin study.", "authors": "Grännö O et al.", "journal": "Journal of Crohn's & colitis", "date": "2026 Apr 8", "url": "https://pubmed.ncbi.nlm.nih.gov/42018767/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "42014032", "title": "Testing for hydroxyzine in human hair after a single controlled administration: First quantitative data.", "authors": "Arbouche N et al.", "journal": "Therapeutic drug monitoring", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42014032/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "42013562", "title": "Immune-related gene expression profiling and alectinib efficacy for patients with ALK-Rearranged non-small cell lung cancer: exploratory analysis of a prospective observational study.", "authors": "Kurosaki T et al.", "journal": "Lung cancer (Amsterdam, Netherlands)", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/42013562/", "sentiment": { "label": "negative", "score": -0.66, "confidence": 0.66 } }, { "source": "pubmed", "pmid": "42013435", "title": "Development of a continuous-flow GC-IRMS method for the simultaneous determination of CO(2) concentration and isotopic composition (δ(13)C(CO2)) in volcanic and geothermal gases.", "authors": "Misseri M et al.", "journal": "Isotopes in environmental and health studies", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42013435/", "sentiment": { "label": "positive", "score": 0.402, "confidence": 0.4 } }, { "source": "pubmed", "pmid": "42011740", "title": "Fragmentation Pathways and Enhanced Detection Sensitivity of OH-PBDEs via LC-ESI-MS(2): A Comprehensive Analytical Investigation.", "authors": "Fu B et al.", "journal": "Analytical chemistry", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42011740/", "sentiment": { "label": "neutral", "score": 0.05, "confidence": 0.05 } }, { "source": "pubmed", "pmid": "42010117", "title": "Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial.", "authors": "Nadeem O et al.", "journal": "Nature medicine", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42010117/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "42008514", "title": "Diagnostic validation of a novel high-sensitivity cardiac troponin T assay.", "authors": "Völschow B et al.", "journal": "European heart journal. Acute cardiovascular care", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42008514/", "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "pubmed", "pmid": "42007733", "title": "Recommendations for HLA Genotyping Data Standards and Clinical Laboratory Staffing Considerations.", "authors": "Spierings E et al.", "journal": "HLA", "date": "2026-04-24", "url": "https://pubmed.ncbi.nlm.nih.gov/42007733/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "42001640", "title": "Evaluation of sampling and DNA extraction strategies for touch DNA recovery from plastic folder, wooden table, and plastic bag surfaces.", "authors": "Ünsal Sapan T et al.", "journal": "Journal of forensic and legal medicine", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/42001640/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "42000139", "title": "Five-year overall survival in JCOG1205/1206: irinotecan or etoposide plus cisplatin for resected high-grade neuroendocrine carcinoma of the lung.", "authors": "Kenmotsu H et al.", "journal": "Lung cancer (Amsterdam, Netherlands)", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42000139/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41999962", "title": "Evolution of patient characteristics and outcomes in ATTR-CM clinical trials: A systematic review.", "authors": "Masri A et al.", "journal": "Progress in cardiovascular diseases", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41999962/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41999559", "title": "Exploring US patient and caregiver perspectives on burden associated with Friedreich Ataxia.", "authors": "Lawson R et al.", "journal": "Journal of patient-reported outcomes", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41999559/", "sentiment": { "label": "negative", "score": -0.44, "confidence": 0.44 } }, { "source": "pubmed", "pmid": "41998286", "title": "SLC33A1 exports oxidized glutathione to maintain endoplasmic reticulum redox homeostasis.", "authors": "Liu S et al.", "journal": "Nature cell biology", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41998286/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41997165", "title": "Signe de cils in peripheral facial palsy.", "authors": "Oancea A et al.", "journal": "Lancet (London, England)", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41997165/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41996931", "title": "Esophageal papillomas and human papillomavirus infection: A case series, scoping review and analysis.", "authors": "Egg M et al.", "journal": "Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41996931/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41996733", "title": "Preparation method for in situ tensile testing in transmission electron microscopy based on push-to-pull chip.", "authors": "Huang R et al.", "journal": "Ultramicroscopy", "date": "2026 Apr 5", "url": "https://pubmed.ncbi.nlm.nih.gov/41996733/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41996200", "title": "Native Top-Down Mass Spectrometry Combined with High-Resolution Charge Variant Analysis of Trastuzumab Originator and Biosimilars.", "authors": "Beaumal C et al.", "journal": "Journal of the American Society for Mass Spectrometry", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41996200/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41996158", "title": "Quantitative Host Cell Protein Analysis of Antibody-Based Protein Therapeutics Using the Orbitrap Astral Mass Spectrometer.", "authors": "Smith J et al.", "journal": "Journal of the American Society for Mass Spectrometry", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41996158/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41993889", "title": "Tackling Neutrophilic Inflammation in Bronchiectasis: From Macrolides to Cathepsin C Inhibitors.", "authors": "Gramegna A et al.", "journal": "Journal of inflammation research", "date": "2026-04-24", "url": "https://pubmed.ncbi.nlm.nih.gov/41993889/", "sentiment": { "label": "negative", "score": -0.25, "confidence": 0.25 } }, { "source": "pubmed", "pmid": "41991782", "title": "Experiences of Migraine and Erenumab Treatment in Japan: Qualitative Interviews with Clinical Trial Participants.", "authors": "Dias-Barbosa C et al.", "journal": "The patient", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41991782/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41989977", "title": "Clusters of Invasive Haemophilus influenzae Type b Disease Among Adults Using Substances or Experiencing Homelessness or Housing Instability - Alaska, Oregon, and Washington, 2023─2025.", "authors": "Collins JP et al.", "journal": "MMWR. Morbidity and mortality weekly report", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41989977/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41986708", "title": "Molecular basis for methylation-sensitive editing by Cas9.", "authors": "Roth MO et al.", "journal": "Nature", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41986708/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41984154", "title": "Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry.", "authors": "Yildirim M et al.", "journal": "Clinical research in cardiology : official journal of the German Cardiac Society", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41984154/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41979819", "title": "Sexual Dysfunction with Antipsychotics: Emerging Clues from a Disproportionality Analysis of the World Health Organization VigiBase.", "authors": "Pavlidis E et al.", "journal": "Drug safety", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41979819/", "sentiment": { "label": "negative", "score": -0.421, "confidence": 0.42 } }, { "source": "pubmed", "pmid": "41972211", "title": "Electroencephalography during acute painful procedures in neonates: a scoping review.", "authors": "Gunawan PY et al.", "journal": "Pain reports", "date": "2026-04-24", "url": "https://pubmed.ncbi.nlm.nih.gov/41972211/", "sentiment": { "label": "negative", "score": -0.44, "confidence": 0.44 } }, { "source": "pubmed", "pmid": "41969623", "title": "Diversity in clinical Trials: The example of systemic lupus erythematosus.", "authors": "Bevan A et al.", "journal": "Contemporary clinical trials communications", "date": "2026-04-24", "url": "https://pubmed.ncbi.nlm.nih.gov/41969623/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41967561", "title": "Pre-analytic error and possible misinterpretation for macrotroponin.", "authors": "Kavsak PA et al.", "journal": "Clinical biochemistry", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41967561/", "sentiment": { "label": "negative", "score": -0.402, "confidence": 0.4 } }, { "source": "pubmed", "pmid": "41966763", "title": "IgE And IgG Antibody Responses to α-Gal and Association With Carotid Stenosis in Swedish Patients.", "authors": "Perusko M et al.", "journal": "Allergy", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41966763/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41965847", "title": "Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance: results from the population-based iStopMM study.", "authors": "Palmason R et al.", "journal": "Blood cancer journal", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41965847/", "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "pubmed", "pmid": "41965748", "title": "Experimental and computational methods for allelic imbalance analysis from single-nucleus RNA-seq data.", "authors": "Simmons SK et al.", "journal": "Genome biology", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41965748/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41963505", "title": "The role of the molecular tumor board: learnings from the ROME trial.", "authors": "Marchetti P et al.", "journal": "NPJ precision oncology", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41963505/", "sentiment": { "label": "negative", "score": -0.382, "confidence": 0.38 } }, { "source": "pubmed", "pmid": "41962871", "title": "An adaptive quantification scheme for profiling serum antibody level in transplant immunology.", "authors": "Schacker T et al.", "journal": "Transplant immunology", "date": "2026 Apr 8", "url": "https://pubmed.ncbi.nlm.nih.gov/41962871/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41960723", "title": "Treatment choice for chronic lymphocytic leukemia after covalent BTKi therapy: a patient and oncologist preference study.", "authors": "Michaels-Igbokwe C et al.", "journal": "Leukemia & lymphoma", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41960723/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41960557", "title": "Clinical phenotypes and molecular endotypes of chronic urticaria: Linking clinical expression to underlying immune mechanisms.", "authors": "Türk M et al.", "journal": "Asia Pacific allergy", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41960557/", "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "pubmed", "pmid": "41959136", "title": "Serum proteomics reveals distinct phenotypic signatures to IL-6 blockade between two immunotherapies.", "authors": "Sniezek C et al.", "journal": "bioRxiv : the preprint server for biology", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41959136/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41957135", "title": "Impact of tumor location on the efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.", "authors": "Ozawa Y et al.", "journal": "British journal of cancer", "date": "2026 Apr 9", "url": "https://pubmed.ncbi.nlm.nih.gov/41957135/", "sentiment": { "label": "negative", "score": -0.718, "confidence": 0.72 } }, { "source": "pubmed", "pmid": "41951782", "title": "Reproductive hormone stability with prolonged intranasal oxytocin in adults with obesity.", "authors": "Galbiati F et al.", "journal": "International journal of obesity (2005)", "date": "2026 Apr 9", "url": "https://pubmed.ncbi.nlm.nih.gov/41951782/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41951141", "title": "Expanding the Global Map of Protein Post Translational Modifications with Immunoaffinity Enrichment and nDIA Analysis on the Orbitrap Astral Mass Spectrometer.", "authors": "Kumar M et al.", "journal": "Molecular & cellular proteomics : MCP", "date": "2026 Apr 6", "url": "https://pubmed.ncbi.nlm.nih.gov/41951141/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41950525", "title": "Toward Molecular Forensics of Agrochemicals with Orbitrap IRMS: Isotopic Fingerprints of Imidacloprid Sources and Elucidating Hydrolysis.", "authors": "Niemann F et al.", "journal": "Journal of the American Society for Mass Spectrometry", "date": "2026 Apr 8", "url": "https://pubmed.ncbi.nlm.nih.gov/41950525/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41950519", "title": "Cross-Sectional Imaging of the WS(2) Nanotube Formation Pathways.", "authors": "Bukvisova K et al.", "journal": "Nano letters", "date": "2026 Apr 8", "url": "https://pubmed.ncbi.nlm.nih.gov/41950519/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41947768", "title": "First 20 Years of Orbitrap Mass Spectrometry as the Mainstream Analytical Technique.", "authors": "Makarov A", "journal": "Mass spectrometry reviews", "date": "2026 Apr 8", "url": "https://pubmed.ncbi.nlm.nih.gov/41947768/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41938080", "title": "Clinical Concordance of Pan Lung Cancer PCR Panel Covering 167 Actionable Variants Across 11 Genes and Other Validated Assays in the LC-SCRUM-Asia Registry.", "authors": "Matsumoto S et al.", "journal": "JTO clinical and research reports", "date": "2026-04-24", "url": "https://pubmed.ncbi.nlm.nih.gov/41938080/", "sentiment": { "label": "negative", "score": -0.542, "confidence": 0.54 } }, { "source": "pubmed", "pmid": "41937341", "title": "Immediate and delayed hypersensitivity to biologicals in children-A practical approach: An EAACI task force report.", "authors": "Mori F et al.", "journal": "Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology", "date": "2026-04-24", "url": "https://pubmed.ncbi.nlm.nih.gov/41937341/", "sentiment": { "label": "negative", "score": -0.226, "confidence": 0.23 } }, { "source": "pubmed", "pmid": "41934444", "title": "Reply.", "authors": "Custovic D et al.", "journal": "The Journal of allergy and clinical immunology", "date": "2026 Apr 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41934444/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41933068", "title": "Longer duration of amenorrhea is associated with lower delay discounting and less hedonic eating in girls and young women with low-weight eating disorders.", "authors": "Wronski ML et al.", "journal": "Scientific reports", "date": "2026 Apr 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41933068/", "sentiment": { "label": "negative", "score": -0.542, "confidence": 0.54 } }, { "source": "pubmed", "pmid": "41928234", "title": "Transcriptomics analysis identifies folding and secretion related genes for improving monoclonal antibody production in Thermothelomyces heterothallica C1.", "authors": "Mäkinen M et al.", "journal": "Microbial cell factories", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41928234/", "sentiment": { "label": "positive", "score": 0.421, "confidence": 0.42 } }, { "source": "pubmed", "pmid": "41926944", "title": "[Use of Omalizumab-biosimilars for CRSwNP in the German Health Care System - a Position Paper of the German Societies for Allergy AeDA and ORL DGHNO-KHC].", "authors": "Klimek L et al.", "journal": "Laryngo- rhino- otologie", "date": "2026-04-24", "url": "https://pubmed.ncbi.nlm.nih.gov/41926944/", "sentiment": { "label": "positive", "score": 0.494, "confidence": 0.49 } }, { "source": "pubmed", "pmid": "41925420", "title": "Harnessing the lung microbiome for precision management of fibrotic lung disease.", "authors": "Leroy S et al.", "journal": "Trends in molecular medicine", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41925420/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41923638", "title": "Learning multi-cellular representations of single-cell transcriptomics data enables characterization of patient-level disease states.", "authors": "Liu T et al.", "journal": "Cell systems", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41923638/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } } ] } }